BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tateishi R, Shiina S, Teratani T, Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma: An analysis of 1000 cases. Cancer 2005;103:1201-9. [DOI: 10.1002/cncr.20892] [Cited by in Crossref: 553] [Cited by in F6Publishing: 510] [Article Influence: 32.5] [Reference Citation Analysis]
Number Citing Articles
1 Mulcahy MF. Management of hepatocellular cancer. Curr Treat Options Oncol. 2005;6:423-435. [PMID: 16107245 DOI: 10.1007/s11864-005-0045-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
2 Khorsandi SE, Heaton N. Contemporary strategies in the management of hepatocellular carcinoma. HPB Surg 2012;2012:154056. [PMID: 23197879 DOI: 10.1155/2012/154056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol. 2008;190:W187-W195. [PMID: 18287411 DOI: 10.2214/ajr.07.2537] [Cited by in Crossref: 57] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
4 Sun H, Ni J, Jiang X, Chen D, Chen Y, Xu L. The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT. Onco Targets Ther 2017;10:3835-42. [PMID: 28814882 DOI: 10.2147/OTT.S137312] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
5 Swan RZ, Sindram D, Martinie JB, Iannitti DA. Operative microwave ablation for hepatocellular carcinoma: complications, recurrence, and long-term outcomes. J Gastrointest Surg. 2013;17:719-729. [PMID: 23404173 DOI: 10.1007/s11605-013-2164-y] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
6 Koda M, Mandai M, Matono T, Sugihara T, Nagahara T, Ueki M, Ohyama K, Hosho K, Murawaki Y. Assessment of the ablated area after radiofrequency ablation by contrast-enhanced sonography; comparison with virtual sonography with magnetic navigation. Clinical Imaging 2010;34:60-4. [DOI: 10.1016/j.clinimag.2009.03.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Liu F, Yu X, Cheng Z, Han Z, Sun Y, Liang P, Zhou F. Comparison of ultrasonography-guided percutaneous microwave ablation for subcapsular and nonsubcapsular hepatocellular carcinoma. European Journal of Radiology 2017;91:93-8. [DOI: 10.1016/j.ejrad.2017.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver 2010;4 Suppl 1:S113-8. [PMID: 21103289 DOI: 10.5009/gnl.2010.4.S1.S113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
9 Paik EK, Kim MS, Choi CW, Jang WI, Lee SH, Choi SH, Kim KB, Lee DH. Dosimetric comparison of volumetric modulated arc therapy with robotic stereotactic radiation therapy in hepatocellular carcinoma. Radiat Oncol J. 2015;33:233-241. [PMID: 26484307 DOI: 10.3857/roj.2015.33.3.233] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
10 Clasen S, Rempp H, Hoffmann R, Graf H, Pereira PL, Claussen CD. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): Is MR guidance more effective than CT guidance? European Journal of Radiology 2014;83:111-6. [DOI: 10.1016/j.ejrad.2013.09.018] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
11 Zhang M, Liang P, Cheng Z, Yu X, Han Z, Yu J. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. International Journal of Hyperthermia 2014;30:134-41. [DOI: 10.3109/02656736.2014.891765] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
12 Burgmans MC, Too CW, Fiocco M, Kerbert AJ, Lo RH, Schaapman JJ, van Erkel AR, Coenraad MJ, Tan BS. Differences in Patient Characteristics and Midterm Outcome Between Asian and European Patients Treated with Radiofrequency Ablation for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2016;39:1708-15. [PMID: 27671151 DOI: 10.1007/s00270-016-1462-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Moribata K, Tamai H, Shingaki N, Mori Y, Shiraki T, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Ichinose M. Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation. World J Hepatol 2012;4:374-81. [PMID: 23355915 DOI: 10.4254/wjg.v4.i12.374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
14 El-Gendi A, El-Shafei M, Abdel-Aziz F, Bedewy E. Intraoperative ablation for small HCC not amenable for percutaneous radiofrequency ablation in Child A cirrhotic patients. J Gastrointest Surg 2013;17:712-8. [PMID: 23179908 DOI: 10.1007/s11605-012-2085-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Venkatesan AM, Wood BJ, Gervais DA. Percutaneous ablation in the kidney. Radiology 2011;261:375-91. [PMID: 22012904 DOI: 10.1148/radiol.11091207] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 6.8] [Reference Citation Analysis]
16 Hendriquez R, Keihanian T, Goyal J, Abraham RR, Mishra R, Girotra M. Radiofrequency ablation in the management of primary hepatic and biliary tumors. World J Gastrointest Oncol 2022; 14(1): 203-215 [DOI: 10.4251/wjgo.v14.i1.203] [Reference Citation Analysis]
17 Fukuda H, Numata K, Moriya S, Shimoyama Y, Ishii T, Nozaki A, Kondo M, Morimoto M, Maeda S, Sakamaki K, Morita S, Tanaka K. Hepatocellular Carcinoma: Concomitant Sorafenib Promotes Necrosis after Radiofrequency Ablation—Propensity Score Matching Analysis. Radiology 2014;272:598-604. [DOI: 10.1148/radiol.14131640] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
18 Seror O. Percutaneous hepatic ablation: What needs to be known in 2014. Diagnostic and Interventional Imaging 2014;95:665-75. [DOI: 10.1016/j.diii.2014.04.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
19 Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, Della Pina C, Bargellini I, Cioni D, Oliveri F, De Simone P, Bartolozzi C, Brunetto M, Filipponi F. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study. Journal of Hepatology 2008;49:217-22. [DOI: 10.1016/j.jhep.2008.03.021] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
20 Yamakado K, Takaki H, Nakatsuka A, Yamaknaka T, Fujimori M, Hasegawa T, Uraki J. Radiofrequency ablation for hepatocellular carcinoma. Gastrointestinal Intervention 2014;3:35-9. [DOI: 10.1016/j.gii.2014.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
21 Eun HS, Lee BS, Kwon IS, Yun GY, Lee ES, Joo JS, Sung JK, Moon HS, Kang SH, Kim JS, Shin HJ, Kim TK, Chun K, Kim SH. Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma. Dig Dis Sci. 2017;62:2586-2600. [PMID: 28744835 DOI: 10.1007/s10620-017-4688-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Takaki H, Yamakado K, Nakatsuka A, Yamada T, Shiraki K, Takei Y, Takeda K. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience. AJR Am J Roentgenol. 2013;200:658-664. [PMID: 23436859 DOI: 10.2214/ajr.12.8691] [Cited by in Crossref: 31] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
23 Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Liver Transpl. 2011;17:556-566. [PMID: 21506244 DOI: 10.1002/lt.22273] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
24 Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-594. [PMID: 18620773 DOI: 10.1016/j.jhep.2008.05.018] [Cited by in Crossref: 124] [Cited by in F6Publishing: 119] [Article Influence: 8.9] [Reference Citation Analysis]
25 Seror O, N'kontchou G, Tin-tin-htar M, Barrucand C, Ganne N, Coderc E, Trinchet JC, Sellier N, Beaugrand M. Radiofrequency Ablation with Internally Cooled versus Perfused Electrodes for the Treatment of Small Hepatocellular Carcinoma in Patients with Cirrhosis. Journal of Vascular and Interventional Radiology 2008;19:718-24. [DOI: 10.1016/j.jvir.2008.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
26 Ito T, Oura S, Nagamine S, Takahashi M, Yamamoto N, Yamamichi N, Earashi M, Doihara H, Imoto S, Mitsuyama S, Akazawa K. Radiofrequency Ablation of Breast Cancer: A Retrospective Study. Clinical Breast Cancer 2018;18:e495-500. [DOI: 10.1016/j.clbc.2017.09.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
27 Choi D, Lim HK, Joh JW, Kim SJ, Kim MJ, Rhim H, Kim YS, Yoo BC, Paik SW, Park CK. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann Surg Oncol. 2007;14:3510-3518. [PMID: 17653800 DOI: 10.1245/s10434-007-9492-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
28 Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, Xu L, Lau WY. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. Eur J Surg Oncol. 2013;39:865-872. [PMID: 23597497 DOI: 10.1016/j.ejso.2013.03.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
29 Kwan J, Appuhamy C, Lim GHT, Huang IKH, Quek L, Pua U. Safety and Efficacy of Percutaneous Thermal Ablation of Juxta-Cardiac Hepatic Tumours. Cardiovasc Intervent Radiol 2018;41:920-7. [PMID: 29582128 DOI: 10.1007/s00270-018-1938-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
30 Chen M, Tan Y, Hu J, Jiang Y, Wang Z, Liu Z, Chen Q. Injectable Immunotherapeutic Thermogel for Enhanced Immunotherapy Post Tumor Radiofrequency Ablation. Small 2021;:e2104773. [PMID: 34729889 DOI: 10.1002/smll.202104773] [Reference Citation Analysis]
31 Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R, Llovet JM. New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene. 2006;25:3848-3856. [PMID: 16799626 DOI: 10.1038/sj.onc.1209548] [Cited by in Crossref: 109] [Cited by in F6Publishing: 100] [Article Influence: 6.8] [Reference Citation Analysis]
32 Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PloS one. 2013;8:e58184. [PMID: 23516447 DOI: 10.1371/journal.pone.0058184.t001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Sato M, Kato N, Tateishi R, Muroyama R, Kowatari N, Li W, Goto K, Otsuka M, Shiina S, Yoshida H. IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. J Gastroenterol. 2014;49:748-754. [PMID: 23689989 DOI: 10.1007/s00535-013-0826-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
34 Cheng Z, Xiao Q, Wang Y, Sun Y, Lu T, Liang P. 915MHz microwave ablation with implanted internal cooled-shaft antenna: initial experimental study in in vivo porcine livers. Eur J Radiol. 2011;79:131-135. [PMID: 20074887 DOI: 10.1016/j.ejrad.2009.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
35 Itoh S, Morita K, Ueda S, Sugimachi K, Yamashita Y, Gion T, Fukuzawa K, Wakasugi K, Taketomi A, Maehara Y. Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Ann Surg Oncol. 2009;16:3299-3307. [PMID: 19826875 DOI: 10.1245/s10434-009-0721-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
36 Subramanian S, Rudich SM, Alqadah A, Karunakaran CP, Rao MB, Mast TD. In vivo thermal ablation monitoring using ultrasound echo decorrelation imaging. Ultrasound Med Biol 2014;40:102-14. [PMID: 24239361 DOI: 10.1016/j.ultrasmedbio.2013.09.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
37 Cloyd JM, Pawlik TM. Diagnostic and therapeutic implications of novel peptides in hepatocellular carcinoma. Hepatology 2018;68:1223-5. [PMID: 29626850 DOI: 10.1002/hep.29923] [Reference Citation Analysis]
38 Solomon SB, Patriciu A, Stoianovici DS. Tumor Ablation Treatment Planning Coupled to Robotic Implementation: A Feasibility Study. Journal of Vascular and Interventional Radiology 2006;17:903-7. [DOI: 10.1097/01.rvi.0000217945.27704.b1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
39 Kuo YC, Chiu YM, Shih WP, Yu HW, Chen CW, Wong PF, Lin WC, Hwang JJ. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol. 2011;6:76. [PMID: 21693003 DOI: 10.1186/1748-717x-6-76] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
40 Ogasawara S, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Kato N. Changes in therapeutic options for hepatocellular carcinoma in Asia. Liver Int 2021. [PMID: 34780081 DOI: 10.1111/liv.15101] [Reference Citation Analysis]
41 Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M. Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 2015;7:21-7. [PMID: 26056497 DOI: 10.2147/HMER.S67940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
42 Kim H, Rhim H, Choi D, Lim HK, Kim YS, Lee WJ, Joh JW. Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: a comparison between radiofrequency ablation and surgery as a first-line treatment. World J Surg. 2010;34:1881-1886. [PMID: 20376449 DOI: 10.1007/s00268-010-0533-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
43 Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336-347. [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 5.0] [Reference Citation Analysis]
44 Lee YH, Hsu CY, Chu CW, Liu PH, Hsia CY, Huang YH, Su CW, Chiou YY, Lin HC, Huo TI. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses. J Clin Gastroenterol. 2015;49:242-249. [PMID: 24714185 DOI: 10.1097/mcg.0000000000000133] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
45 Ke S, Ding XM, Qian XJ, Zhou YM, Cao BX, Gao K, Sun WB. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified? World J Gastroenterol 2013;19:7389-98. [PMID: 24259969 DOI: 10.3748/wjg.v19.i42.7389] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
46 Seo JH, Kim DH, Cho E, Jun CH, Park SY, Cho SB, Park CH, Kim HS, Choi SK, Rew JS. Characteristics and Outcomes of Extreme Elderly Patients With Hepatocellular Carcinoma in South Korea. In Vivo. 2019;33:145-154. [PMID: 30587615 DOI: 10.21873/invivo.11451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
47 Goto T, Yoshida H, Tateishi R, Enooku K, Goto E, Sato T, Ohki T, Masuzaki R, Imamura J, Shiina S. Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation. Hepatol Int. 2011;5:767-773. [PMID: 21484129 DOI: 10.1007/s12072-011-9255-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
48 Du L, Zhou J, Wang X, Sheng L, Wang G, Xie X, Xu G, Zhao L, Liao Y, Tang J. Effect of local hyperthermia induced by nanometer magnetic fluid on the rabbit VX2 liver tumor model. Progress in Natural Science 2009;19:1705-12. [DOI: 10.1016/j.pnsc.2009.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
49 Dong Y, Wang W, Gan Y, Huang B, Ding H. Radiofrequency ablation guided by contrast-enhanced ultrasound for hepatic malignancies: Preliminary results. Clinical Radiology 2014;69:1129-35. [DOI: 10.1016/j.crad.2014.06.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
50 Kondo Y, Yoshida H, Tomizawa Y, Tateishi R, Shiina S, Tagawa K, Omata M. Percutaneous radiofrequency ablation of hepatocellular carcinoma in 14 patients undergoing regular hemodialysis for end-stage renal disease. AJR Am J Roentgenol. 2009;193:964-969. [PMID: 19770317 DOI: 10.2214/ajr.08.2236] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
51 Ryu T, Takami Y, Tsutsumi N, Tateishi M, Mikagi K, Wada Y, Saitsu H. Simultaneous microwave coagulo-necrotic therapy (MCN) and laparoscopic splenectomy for the treatment of hepatocellular carcinoma with cirrhotic hypersplenism. Surg Today 2017;47:548-54. [DOI: 10.1007/s00595-016-1411-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
52 Inokawa Y, Inaoka K, Sonohara F, Hayashi M, Kanda M, Nomoto S. Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors. Oncol Lett 2016;12:3662-8. [PMID: 27900050 DOI: 10.3892/ol.2016.5141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
53 Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-73. [DOI: 10.1002/hep.23725] [Cited by in Crossref: 323] [Cited by in F6Publishing: 320] [Article Influence: 26.9] [Reference Citation Analysis]
54 Rhim H, Choi D, Kim YS, Lim HK, Choe BK. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol. 2010;75:253-258. [PMID: 19427152 DOI: 10.1016/j.ejrad.2009.04.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
55 Takada H, Tsuchiya K, Yasui Y, Nakakuki N, Tamaki N, Suzuki S, Nakanishi H, Itakura J, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Izumi N. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Cancer Med 2016;5:3111-20. [PMID: 27748052 DOI: 10.1002/cam4.932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
56 Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y. Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment. Dig Dis Sci 2010;55:2095-101. [DOI: 10.1007/s10620-009-0954-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
57 Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Sakamoto A, Henmi S, Hatamaru K, Ishikawa T, Saito S, Nasu A, Kita R, Kimura T, Arimoto A, Osaki Y. Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma. BMC Gastroenterol 2011;11:143. [PMID: 22204311 DOI: 10.1186/1471-230X-11-143] [Cited by in Crossref: 49] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
58 Shiina S. Image-guided percutaneous ablation therapies for hepatocellular carcinoma. J Gastroenterol 2009;44:122-31. [DOI: 10.1007/s00535-008-2263-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
59 Park Y, Choi D, Lim HK, Rhim H, Kim Y, Kim SH, Lee WJ. Growth Rate of New Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation: Evaluation with Multiphase CT. American Journal of Roentgenology 2008;191:215-20. [DOI: 10.2214/ajr.07.3297] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
60 Lafon C, Melodelima D, Salomir R, Chapelon JY. Interstitial devices for minimally invasive thermal ablation by high-intensity ultrasound. Int J Hyperthermia 2007;23:153-63. [PMID: 17578339 DOI: 10.1080/02656730601173029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
61 Li WH, Ma KW, Cheng M, Chui KH, Chan PT, Chu WH, Fung HS, Kowk CH, Cheung MT. Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients. ANZ J Surg 2010;80:714-21. [PMID: 21040332 DOI: 10.1111/j.1445-2197.2010.05434.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
62 Yacoub JH, Hsu CC, Fishbein TM, Mauro D, Moon A, He AR, Bashir MR, Burke LMB. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation-part one: curative intention. Abdom Radiol (NY) 2021;46:3528-39. [PMID: 33835223 DOI: 10.1007/s00261-021-03069-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Kim JS, Kim HS, Myung DS, Lee GH, Park KJ, Cho SB, Joo YE, Choi SK. A case of diaphragmatic hernia induced by radiofrequency ablation for hepatocellular carcinoma. Korean J Gastroenterol 2013;62:174-8. [PMID: 24077629 DOI: 10.4166/kjg.2013.62.3.174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
64 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Masuzaki R, Yoshida H, Tateishi R, Shiina S, Omata M. Hepatocellular carcinoma in viral hepatitis: improving standard therapy. Best Pract Res Clin Gastroenterol. 2008;22:1137-1151. [PMID: 19187872 DOI: 10.1016/j.bpg.2008.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
66 Watanabe H, Kanematsu M, Goshima S, Yoshida M, Kawada H, Kondo H, Moriyama N. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy? AJR Am J Roentgenol. 2012;198:589-595. [PMID: 22357997 DOI: 10.2214/ajr.11.6844] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
67 Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Korean J Intern Med. 2016;31:242-252. [PMID: 26874512 DOI: 10.3904/kjim.2015.112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
68 Awad MM, Devgan L, Kamel IR, Torbensen M, Choti MA. Microwave ablation in a hepatic porcine model: correlation of CT and histopathologic findings. HPB (Oxford). 2007;9:357-362. [PMID: 18345319 DOI: 10.1080/13651820701646222] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 4.1] [Reference Citation Analysis]
69 Kairaluoma V, Karjalainen M, Pohjanen VM, Saarnio J, Niemelä J, Huhta H, Helminen O. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 years. Minerva Surg 2021;76:252-63. [PMID: 33890436 DOI: 10.23736/S2724-5691.21.08426-1] [Reference Citation Analysis]
70 Hirooka M, Ochi H, Koizumi Y, Tokumoto Y, Hiraoka A, Kumagi T, Abe M, Tanaka H, Hiasa Y. Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation. Mol Clin Oncol 2014;2:182-6. [PMID: 24649330 DOI: 10.3892/mco.2013.229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
71 Fujimori M, Takaki H, Nakatsuka A, Uraki J, Yamanaka T, Hasegawa T, Shiraki K, Takei Y, Sakuma H, Yamakado K. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience. J Vasc Interv Radiol 2013;24:655-66. [PMID: 23428356 DOI: 10.1016/j.jvir.2012.12.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
72 Berry K, Ioannou GN. Are Patients with Child's A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?: Liver Transplantation for Hepatocellular Carcinoma. American Journal of Transplantation 2012;12:706-17. [DOI: 10.1111/j.1600-6143.2011.03853.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
73 Nault J, Sutter O, Nahon P, Ganne-carrié N, Séror O. Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations. Journal of Hepatology 2018;68:783-97. [DOI: 10.1016/j.jhep.2017.10.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 24.8] [Reference Citation Analysis]
74 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58. [PMID: 22190656 DOI: 10.1148/radiol.11110144] [Cited by in Crossref: 211] [Cited by in F6Publishing: 202] [Article Influence: 21.1] [Reference Citation Analysis]
75 Kanogawa N, Chiba T, Ogasawara S, Ooka Y, Suzuki E, Motoyama T, Saito T, Sekimoto T, Tawada A, Maruyama H, Yoshikawa M, Yokosuka O. Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma. Case Rep Oncol 2014;7:833-9. [PMID: 25685134 DOI: 10.1159/000370305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
76 Kao WY, Su CW, Chiou YY, Chiu NC, Liu CA, Fang KC, Huo TI, Huang YH, Chang CC, Hou MC, Lin HC, Wu JC. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation. Radiology. 2017;285:670-680. [PMID: 28562211 DOI: 10.1148/radiol.2017162382] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
77 Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg. 2009;13:318-324. [PMID: 18825464 DOI: 10.1007/s11605-008-0710-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
78 Choi D, Lim HK, Rhim H, Kim Y, Yoo BC, Paik SW, Joh J, Park CK. Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors. Ann Surg Oncol 2007;14:2319-29. [DOI: 10.1245/s10434-006-9220-8] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 6.3] [Reference Citation Analysis]
79 Kalra N, Gupta P, Chawla Y, Khandelwal N. Locoregional treatment for hepatocellular carcinoma: The best is yet to come. World J Radiol 2015; 7(10): 306-318 [PMID: 26516427 DOI: 10.4329/wjr.v7.i10.306] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
80 Real M, Bianchi L, Vilana R, Burrel M, Rimola J. Tratamiento percutáneo e intraarterial del carcinoma hepatocelular. Radiología 2010;52:399-413. [DOI: 10.1016/j.rx.2010.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
81 N'kontchou G, Mahamoudi A, Aout M, Ganne-carrié N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O. Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-83. [DOI: 10.1002/hep.23181] [Cited by in Crossref: 284] [Cited by in F6Publishing: 268] [Article Influence: 21.8] [Reference Citation Analysis]
82 Kondo Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Masuzaki R, Asaoka Y. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis. Liver Int. 2011;31:197-205. [PMID: 21159122 DOI: 10.1111/j.1478-3231.2010.02415.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
83 Arienti V, Pretolani S, Pacella CM, Magnolfi F, Caspani B, Francica G, Megna AS, Regine R, Sponza M, Antico E, Di Lascio FML. Complications of Laser Ablation for Hepatocellular Carcinoma: A Multicenter Study. Radiology 2008;246:947-55. [DOI: 10.1148/radiol.2463070390] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
84 Guan TP, Fang CH, Yang J, Xiang N, Chen QS, Zhong SZ. A Comparison between Three-Dimensional Visualization Guided Hepatectomy and Ultrasonography Guided Radiofrequency Ablation in the Treatment of Small Hepatocellular Carcinoma within the Milan Criteria. Biomed Res Int 2016;2016:8931732. [PMID: 27294142 DOI: 10.1155/2016/8931732] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Tsuchiya K, Komuta M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Sakamoto M, Izumi N. Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation. Oncology 2011;80:278-88. [DOI: 10.1159/000328448] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
86 Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK; Interventional Oncology Task Force and Standards Division, Society of Interventional Radiology. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol 2009;20:3-8. [PMID: 18948025 DOI: 10.1016/j.jvir.2008.09.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
87 Chang IS, Rhim H, Kim SH, Kim YS, Choi D, Park Y, Lim HK. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance. AJR Am J Roentgenol. 2010;195:1131-1136. [PMID: 20966318 DOI: 10.2214/ajr.09.3946] [Cited by in Crossref: 36] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
88 Permpongkosol S, Nicol TL, Khurana H, Link RE, Zhai QJ, Kavoussi LR, Solomon SB. Thermal maps around two adjacent cryoprobes creating overlapping ablations in porcine liver, lung, and kidney. J Vasc Interv Radiol. 2007;18:283-287. [PMID: 17327563 DOI: 10.1016/j.jvir.2006.12.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
89 Tateishi R, Shiina S, Ohki T, Sato T, Masuzaki R, Imamura J, Goto E, Goto T, Yoshida H, Obi S, Sato S, Kanai F, Yoshida H, Omata M. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 2009;44:142-6. [DOI: 10.1007/s00535-008-2247-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
90 Ryu T, Takami Y, Wada Y, Sasaki S, Imamura H, Ureshino H, Saitsu H. Combined hepatectomy and microwave ablation for multifocal hepatocellular carcinoma: Long-term outcomes and prognostic factors. Asian J Surg 2021;44:186-91. [PMID: 32473893 DOI: 10.1016/j.asjsur.2020.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am 2006;35:201-19. [PMID: 16530121 DOI: 10.1016/j.gtc.2005.12.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
92 Kim YS, Rhim H, Paik SS. Radiofrequency ablation of the liver in a rabbit model: creation of artificial ascites to minimize collateral thermal injury to the diaphragm and stomach. J Vasc Interv Radiol. 2006;17:541-547. [PMID: 16567679 DOI: 10.1097/01.rvi.0000208305.65202.84] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 1.9] [Reference Citation Analysis]
93 Nishikawa H, Osaki Y, Iguchi E, Takeda H, Matsuda F, Nakajima J, Sakamoto A, Hatamaru K, Saito S, Nasu A, Kita R, Kimura T. Radiofrequency ablation for hepatocellular carcinoma: the relationship between a new grading system for the ablative margin and clinical outcomes. J Gastroenterol 2013;48:951-65. [PMID: 23065022 DOI: 10.1007/s00535-012-0690-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
94 Yang W, Yan K, Wu GX, Wu W, Fu Y, Lee JC, Zhang ZY, Wang S, Chen MH. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes. World J Gastroenterol 2015; 21(5): 1554-1566 [PMID: 25663774 DOI: 10.3748/wjg.v21.i5.1554] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
95 Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249:20-25. [PMID: 19106671 DOI: 10.1097/sla.0b013e31818eec29] [Cited by in Crossref: 216] [Cited by in F6Publishing: 86] [Article Influence: 16.6] [Reference Citation Analysis]
96 Hänsler J, Frieser M, Tietz V, Uhlke D, Wissniowski T, Bernatik T, Hothorn T, Hahn EG, Strobel D. Percutaneous Radiofrequency Ablation of Liver Tumors Using Multiple Saline-Perfused Electrodes. Journal of Vascular and Interventional Radiology 2007;18:405-10. [DOI: 10.1016/j.jvir.2006.12.729] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
97 Weinberg BD, Krupka TM, Haaga JR, Exner AA. Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model. Radiology 2008;246:796-803. [PMID: 18309015 DOI: 10.1148/radiol.2463070228] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
98 Yuan Z, Wang Y, Hu C, Gao W, Zheng J, Li W. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival. Technol Cancer Res Treat 2018;17:1533033818801362. [PMID: 30244651 DOI: 10.1177/1533033818801362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
99 Korutz AW, Sato KT. Radiofrequency ablation of a solitary liver metastasis complicated by colonic perforation. Semin Intervent Radiol 2011;28:171-4. [PMID: 22654256 DOI: 10.1055/s-0031-1280658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
100 Fukuda H, Ito R, Ohto M, Sakamoto A, Karasawa E, Yamaguchi T, Shinozuka N, Zhu H, Wanga Z. Treatment of Small Hepatocellular Carcinomas with US-Guided High-Intensity Focused Ultrasound. Ultrasound in Medicine & Biology 2011;37:1222-9. [DOI: 10.1016/j.ultrasmedbio.2011.04.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
101 Qian LX, Wei HT, Hu XD. Current situation and progress of local ablation therapy for hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(18): 1955-1961 [DOI: 10.11569/wcjd.v16.i18.1955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
102 Hsieh M, Chen C, Chen Y, Chou C. Hemobilia after CT-guided radiofrequency ablation of liver tumors: frequency, risk factors, and clinical significance. Abdom Radiol 2019;44:337-45. [DOI: 10.1007/s00261-018-1693-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
103 Lee JY, Kim YH, Roh YH, Roh KB, Kim KW, Kang SH, Baek YH, Lee SW, Han SY, Kwon HJ, Cho JH. Intraoperative radiofrequency ablation for hepatocellular carcinoma in 112 patients with cirrhosis: a surgeon's view. Ann Surg Treat Res 2016;90:147-56. [PMID: 26942158 DOI: 10.4174/astr.2016.90.3.147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
104 Sato K, Taniki N, Kanazawa R, Shimizu M, Ishii S, Ohama H, Takawa M, Nagamatsu H, Imai Y, Shiina S. Efficacy and Safety of Deep Sedation in Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma. Adv Ther 2019;36:344-54. [PMID: 30607546 DOI: 10.1007/s12325-018-0865-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
105 Girotra M, Soota K, Dhaliwal AS, Abraham RR, Garcia-Saenz-de-Sicilia M, Tharian B. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging? World J Gastrointest Endosc 2018; 10(2): 56-68 [PMID: 29467916 DOI: 10.4253/wjge.v10.i2.56] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
106 Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Actual 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma: A Single-Center Experience in Japan. Ann Surg Oncol. 2019;26:4126-4133. [PMID: 31359277 DOI: 10.1245/s10434-019-07646-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
107 Furuta A, Isoda H, Koyama T, Todo G, Osaki Y, Togashi K. Biliary peritonitis after radiofrequency ablation diagnosed by gadoxetic acid-enhanced MR imaging. Korean J Radiol 2013;14:914-7. [PMID: 24265566 DOI: 10.3348/kjr.2013.14.6.914] [Reference Citation Analysis]
108 Ni J, Liu S, Xu L, Sun H, Chen Y. Transarterial chemoembolization combined with percutaneous radiofrequency ablation versus TACE and PRFA monotherapy in the treatment for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 2013;139:653-9. [DOI: 10.1007/s00432-012-1369-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
109 Park MJ, Kim YS, Rhim H, Lim HK, Lee MW, Choi D. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique. J Vasc Interv Radiol. 2011;22:771-779. [PMID: 21616430 DOI: 10.1016/j.jvir.2011.02.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
110 Yune Y, Kim S, Song I, Chun K. Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for small hepatocellular carcinoma: short-term result. Korean J Hepatobiliary Pancreat Surg 2015;19:173-80. [PMID: 26693237 DOI: 10.14701/kjhbps.2015.19.4.173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
111 Liu C, Chiu N, Chiou Y. Massive hematemesis after radiofrequency ablation of metastatic liver tumor with successful hemostasis achieved through transarterial embolization. Clinical Imaging 2018;51:192-5. [DOI: 10.1016/j.clinimag.2018.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
112 Li M, Li Z, Yu X, Liang P, Gao Y, Han Z, Liu F, Dong J. Percutaneous radio-frequency ablation of hepatocellular carcinoma adjacent to the gastrointestinal tract. International Journal of Hyperthermia 2016;32:600-6. [DOI: 10.3109/02656736.2016.1157904] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
113 Yokoyama K, Anan A, Iwata K, Nishizawa S, Morihara D, Ueda S, Sakurai K, Iwashita H, Hirano G, Sakamoto M. Limitation of repeated radiofrequency ablation in hepatocellular carcinoma: proposal of a three (times) × 3 (years) index. J Gastroenterol Hepatol. 2012;27:1044-1050. [PMID: 22433056 DOI: 10.1111/j.1440-1746.2012.07134.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
114 Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA, Mueller PR. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol. 2010;20:877-885. [PMID: 19760232 DOI: 10.1007/s00330-009-1610-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 4.4] [Reference Citation Analysis]
115 Ang E, Ng KT, Lee ZX, Ti LK, Chaw SH, Wang CY. Effect of regional anaesthesia only versus general anaesthesia on cancer recurrence rate: A systematic review and meta-analysis with trial sequential analysis. Journal of Clinical Anesthesia 2020;67:110023. [DOI: 10.1016/j.jclinane.2020.110023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Xu C, Zheng H, Shi T, Qi J, Zhao X, Li J, Feng Y, Zhu Q. A prediction model of major complications after radiofrequency ablation for recurrent hepatocellular carcinoma patients. Eur J Radiol 2021;140:109635. [PMID: 34024632 DOI: 10.1016/j.ejrad.2021.109635] [Reference Citation Analysis]
117 Zhang X, Zhou L, Chen B, Hu S, Wachtel MS, Frezza EE. Retracted: Microwave ablation with cooled‐tip electrode for liver cancer: An analysis of 160 cases. Minimally Invasive Therapy & Allied Technologies 2009;17:303-7. [DOI: 10.1080/13645700802383926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
118 Dan J, Zhang Y, Peng Z, Huang J, Gao H, Xu L, Chen M. Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One. 2013;8:e58184. [PMID: 23516447 DOI: 10.1371/journal.pone.0058184] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 8.4] [Reference Citation Analysis]
119 Spychalski P, Kobiela J, Antoszewska M, Błażyńska-Spychalska A, Jereczek-Fossa BA, Høyer M. Patient specific outcomes of charged particle therapy for hepatocellular carcinoma - A systematic review and quantitative analysis. Radiother Oncol 2019;132:127-34. [PMID: 30825961 DOI: 10.1016/j.radonc.2018.12.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
120 Zhang YJ, Chen MS. Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma. World J Hepatol 2010; 2(4): 146-150 [PMID: 21160987 DOI: 10.4254/wjh.v2.i4.146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
121 Yi Y, Zhang Y, Wei Q, Zhao L, Han J, Song Y, Ding Y, Lu G, Liu J, Ding H, Dai F, Tang X. Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone. Chin J Cancer Res 2014;26:112-8. [PMID: 24653633 DOI: 10.3978/j.issn.1000-9604.2014.02.09] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
122 Matono T, Koda M, Murawaki Y. Contrast-enhanced sonography with perflubutane revealing active bleeding as a complication of radiofrequency ablation. Hepatology 2012;55:649-50. [PMID: 22006455 DOI: 10.1002/hep.24745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
123 Miyayama S, Yamashiro M, Sugimori N, Ikeda R, Okimura K, Sakuragawa N. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software. J Vasc Interv Radiol 2019;30:10-8. [PMID: 30580809 DOI: 10.1016/j.jvir.2018.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
124 Sato M, Tateishi R, Yasunaga H, Horiguchi H, Yoshida H, Matsuda S, Koike K. Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 2012;47:1125-33. [DOI: 10.1007/s00535-012-0569-0] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
125 Tajiri K, Baba H, Kawai K, Minemura M, Yasumura S, Takahara T, Sugiyama T. Neutrophil-to-lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection. J Gastroenterol Hepatol 2016;31:1291-9. [PMID: 26729319 DOI: 10.1111/jgh.13287] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
126 Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2008;66:200-7. [DOI: 10.1016/j.critrevonc.2008.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
127 Lee SH, Jin YJ, Lee JW. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Medicine (Baltimore) 2017;96:e8486. [PMID: 29095307 DOI: 10.1097/MD.0000000000008486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
128 Theodoropoulos J, Brooks A. Inconsistency in the Management of Patients with Hepatocellular Carcinoma: The Need for a Strict Protocol. The American Surgeon 2011;77:207-14. [DOI: 10.1177/000313481107700223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
129 Ahmad MIM. Radiofrequency ablation with monopolar cluster versus bipolar multipolar electrodes for the ablation of ⩾2.5cm hepatocellular carcinoma. The Egyptian Journal of Radiology and Nuclear Medicine 2016;47:1443-9. [DOI: 10.1016/j.ejrnm.2016.08.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
130 Liu D, Liu M, Su L, Wang Y, Zhang X, Long H, Kuang M, Xie X, Lin M. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome. J Vasc Interv Radiol 2019;30:1879-86. [PMID: 31669087 DOI: 10.1016/j.jvir.2019.07.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
131 Tani S, Tatli S, Hata N, Garcia-Rojas X, Olubiyi OI, Silverman SG, Tokuda J. Three-dimensional quantitative assessment of ablation margins based on registration of pre- and post-procedural MRI and distance map. Int J Comput Assist Radiol Surg 2016;11:1133-42. [PMID: 27038962 DOI: 10.1007/s11548-016-1398-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
132 Sato M, Tateishi R, Yasunaga H, Matsui H, Horiguchi H, Fushimi K, Koike K. Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: A nationwide survey. J Gastroenterol Hepatol. 2017;32:1873-1878. [PMID: 28266772 DOI: 10.1111/jgh.13780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
133 Catalano O, Izzo F, Vallone P, Sandomenico F, Albino V, Nunziata A, Fusco R, Petrillo A. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience. Acta Radiol 2015;56:133-42. [PMID: 24523360 DOI: 10.1177/0284185114521108] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
134 Ramacciato G, Mercantini P, Petrucciani N, Ravaioli M, Cucchetti A, Del Gaudio M, Cescon M, Ziparo V, Pinna AD. Does Surgical Resection Have a Role in the Treatment of Large or Multinodular Hepatocellular Carcinoma? The American Surgeon 2010;76:1189-97. [DOI: 10.1177/000313481007601116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
135 Zhang L, Ge N, Chen Y, Xie X, Yin X, Gan Y, Zhang B, Zhang J, Chen R, Wang Y, Ye S, Ren Z. Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0532-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
136 Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684-692. [PMID: 17093964 DOI: 10.1007/s00330-006-0461-5] [Cited by in Crossref: 229] [Cited by in F6Publishing: 218] [Article Influence: 14.3] [Reference Citation Analysis]
137 Hasegawa K, Makuuchi M, Kudo M, Okazaki M. Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma: Reply. Journal of Hepatology 2009;50:1052-3. [DOI: 10.1016/j.jhep.2009.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
138 Fabritius MP, Ben Khaled N, Kunz WG, Ricke J, Seidensticker M. Image-Guided Local Treatment for Unresectable Intrahepatic Cholangiocarcinoma-Role of Interventional Radiology. J Clin Med 2021;10:5574. [PMID: 34884275 DOI: 10.3390/jcm10235574] [Reference Citation Analysis]
139 Zhang K, Jiang L, Jia Z, Zhang Y, He R, Ding Z, Mu Y. Radiofrequency ablation plus devascularization is the preferred treatment of hepatocellular carcinoma with esophageal varices. Dig Dis Sci 2015;60:1490-501. [PMID: 25431044 DOI: 10.1007/s10620-014-3455-1] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
140 Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569-77; quiz 578. [PMID: 22158026 DOI: 10.1038/ajg.2011.425] [Cited by in Crossref: 406] [Cited by in F6Publishing: 385] [Article Influence: 36.9] [Reference Citation Analysis]
141 Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245-1255. [PMID: 22353262 DOI: 10.1016/s0140-6736(11)61347-0] [Cited by in Crossref: 2892] [Cited by in F6Publishing: 1689] [Article Influence: 289.2] [Reference Citation Analysis]
142 Maeda T, Hong J, Konishi K, Nakatsuji T, Yasunaga T, Yamashita Y, Taketomi A, Kotoh K, Enjoji M, Nakashima H, Tanoue K, Maehara Y, Hashizume M. Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system. Surg Endosc 2009;23:1048-53. [PMID: 18813998 DOI: 10.1007/s00464-008-0123-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
143 Dirican A, Karakas S. What Should Be the Rules for Downstaging for Hepatocellular Carcinoma? J Gastrointest Cancer 2020;51:1148-51. [PMID: 32839945 DOI: 10.1007/s12029-020-00490-0] [Reference Citation Analysis]
144 Ma KW, Chok KSH, She WH, Chan ACY, Cheung TT, Dai WC, Fung JYY, Lo CM. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma: A Propensity Score Matched Analysis. Liver Transpl 2018;24:1062-9. [PMID: 29451360 DOI: 10.1002/lt.25033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
145 Yamagishi S, Midorikawa Y, Nakayama H, Higaki T, Moriguchi M, Aramaki O, Yamazaki S, Tsuji S, Takayama T. Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Hepatol Res 2018;49:432-40. [DOI: 10.1111/hepr.13293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
146 Kadivar F, Soulen MC. Enhancing Ablation: Synergies with Regional and Systemic Therapies. Journal of Vascular and Interventional Radiology 2010;21:S251-6. [DOI: 10.1016/j.jvir.2010.01.048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
147 Romero Gutiérrez M, Ruano Díaz L, Muñoz López D, Artaza Varasa T, González de Frutos C, Sánchez Ruano JJ, de la Cruz Pérez G, Gómez Rodríguez R. [Percutaneous ablation of hepatocellular carcinoma in older patients in clinical practice]. Gastroenterol Hepatol 2015;38:54-61. [PMID: 25499846 DOI: 10.1016/j.gastrohep.2014.11.002] [Reference Citation Analysis]
148 Yamamoto J, Kosuge T, Saiura A, Sakamoto Y, Shimada K, Sano T, Takayama T, Sugawara Y, Yamaguchi T, Kokudo N, Makuuchi M. Effectiveness of Hepatic Resection for Early-stage Hepatocellular Carcinoma in Cirrhotic Patients: Subgroup Analysis according to Milan Criteria. Japanese Journal of Clinical Oncology 2007;37:287-95. [DOI: 10.1093/jjco/hym025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
149 Fan W, Li X, Zhang L, Jiang H, Zhang J. Comparison of microwave ablation and multipolar radiofrequency ablation in vivo using two internally cooled probes. AJR Am J Roentgenol. 2012;198:W46-W50. [PMID: 22194514 DOI: 10.2214/ajr.11.6707] [Cited by in Crossref: 55] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
150 Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11-17. [PMID: 19924474 DOI: 10.1007/s00270-009-9736-y] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
151 Marrero JA, Welling T. Modern Diagnosis and Management of Hepatocellular Carcinoma. Clinics in Liver Disease 2009;13:233-47. [DOI: 10.1016/j.cld.2009.02.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
152 Kawamura R, Seki T, Umehara H, Ikeda K, Inokuchi R, Asayama T, Yamaguchi T, Takahashi Y, Sakao M, Lencioni R. Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation. Cardiovasc Intervent Radiol. 2012;35:325-333. [PMID: 21607824 DOI: 10.1007/s00270-011-0184-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
153 Qiu-Jie S, Zhi-Yu H, Xiao-Xia N, Wen-Yuan S, Yuan-Yuan S, Liu H, Xin L, Ping L. Feasible temperature of percutaneous microwave ablation of dog liver abutting the bowel. Int J Hyperthermia 2011;27:124-31. [PMID: 21204623 DOI: 10.3109/02656736.2010.508763] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
154 Yoon K, Kwak J, Cho B, Park JH, Yoon SM, Lee SW, Kim JH. Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements. PLoS One 2016;11:e0166927. [PMID: 27875568 DOI: 10.1371/journal.pone.0166927] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
155 Liang HY, Guo QY, Sun W, Mao XN, Wen F, Shan M, Zhao G, Wang XH, Lu ZM. Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular Carcinoma. Cancer Biother Radiopharm 2015;30:427-32. [PMID: 26683133 DOI: 10.1089/cbr.2015.1884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
156 Kanogawa N, Ogasawara S, Ooka Y, Inoue M, Wakamatsu T, Yokoyama M, Maruta S, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Koroki K, Kanzaki H, Maeda T, Kobayashi K, Kiyono S, Nakamura M, Kondo T, Saito T, Motoyama T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato J, Takemura R, Nozaki-Taguchi N, Shiroh I, Yokosuka O, Kato N. Propofol versus midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma. JGH Open 2021;5:273-9. [PMID: 33553667 DOI: 10.1002/jgh3.12483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
157 Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007;72 Suppl 1:98-103. [PMID: 18087189 DOI: 10.1159/000111714] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 4.7] [Reference Citation Analysis]
158 Garrean S, Hering J, Saied A, Helton WS, Espat NJ. Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg. 2008;195:508-520. [PMID: 18361927 DOI: 10.1016/j.amjsurg.2007.06.024] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 6.6] [Reference Citation Analysis]
159 Hiraoka A, Ichiryu M, Tazuya N, Ochi H, Tanabe A, Nakahara H, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Clinical translation in the treatment of hepatocellular carcinoma following the introduction of contrast-enhanced ultrasonography with Sonazoid. Oncol Lett 2010;1:57-61. [PMID: 22966256 DOI: 10.3892/ol_00000010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
160 Wang JH, Wang CC, Hung CH, Chen CL, Lu SN. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma. J Hepatol. 2012;56:412-418. [PMID: 21756858 DOI: 10.1016/j.jhep.2011.05.020] [Cited by in Crossref: 182] [Cited by in F6Publishing: 189] [Article Influence: 16.5] [Reference Citation Analysis]
161 Yoo TG, Cranshaw I, Broom R, Pandanaboyana S, Bartlett A. Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit? The Breast 2017;32:162-72. [DOI: 10.1016/j.breast.2017.02.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
162 Granito A, Bolondi L. Medical treatment of hepatocellular carcinoma. Mediterr J Hematol Infect Dis 2009;1:e2009021. [PMID: 21415957 DOI: 10.4084/MJHID.2009.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
163 Ryu T, Takami Y, Wada Y, Tateishi M, Matsushima H, Mikagi K, Saitsu H. Double- and Triple-Positive Tumor Markers Predict Early Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh Class A. J Gastrointest Surg 2017;21:957-66. [PMID: 28299619 DOI: 10.1007/s11605-017-3394-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
164 Kim JE, Kim YS, Rhim H, Lim HK, Lee MW, Choi D, Shin SW, Cho SK. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79:e80-e84. [PMID: 21514757 DOI: 10.1016/j.ejrad.2011.03.090] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
165 Inoue T, Kudo M, Hatanaka K, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Minami Y, Sakurai T. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT. Oncology. 2013;84 Suppl 1:51-57. [PMID: 23428859 DOI: 10.1159/000345890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
166 Ohri N, Dawson LA, Krishnan S, Seong J, Cheng JC, Sarin SK, Kinkhabwala M, Ahmed MM, Vikram B, Coleman CN, Guha C. Radiotherapy for Hepatocellular Carcinoma: New Indications and Directions for Future Study. J Natl Cancer Inst. 2016;108. [PMID: 27377923 DOI: 10.1093/jnci/djw133] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
167 Yamamoto M, Ariizumi S, Katagiri S, Kotera Y, Takahashi Y. The value of anatomical liver sectionectomy for patients with a solitary hepatocellular carcinoma from 2 to 5 cm in greatest diameter: Sectionectomy for HCC From 2 to 5 cm. J Surg Oncol 2009;100:585-8. [DOI: 10.1002/jso.21363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
168 Hong K, Georgiades CS, Geschwind JF. Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques. Nat Clin Pract Oncol. 2006;3:315-324. [PMID: 16757969 DOI: 10.1038/ncponc0512] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
169 Goossens N, Singal AG, King LY, Andersson KL, Fuchs BC, Besa C, Taouli B, Chung RT, Hoshida Y. Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis. Clin Transl Gastroenterol 2017;8:e101. [PMID: 28640287 DOI: 10.1038/ctg.2017.26] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 12.8] [Reference Citation Analysis]
170 Tang K, Choy V, Chopra R, Bronskill MJ. Conformal thermal therapy using planar ultrasound transducers and adaptive closed-loop MR temperature control: demonstration in gel phantoms and ex vivo tissues. Phys Med Biol 2007;52:2905-19. [DOI: 10.1088/0031-9155/52/10/018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
171 Kuroda H, Nagasawa T, Fujiwara Y, Sato H, Abe T, Kooka Y, Endo K, Oikawa T, Sawara K, Takikawa Y. Comparing the Safety and Efficacy of Microwave Ablation Using ThermosphereTM Technology versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Propensity Score-Matched Analysis. Cancers (Basel) 2021;13:1295. [PMID: 33803926 DOI: 10.3390/cancers13061295] [Reference Citation Analysis]
172 Kalra N, Kang M, Duseja AK, Bhatia A, Singh V, Dhiman RK, Rajwanshi A, Chawla YK, Khandelwal N. Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma. Indian J Med Res 2017;146:S30-7. [PMID: 29578192 DOI: 10.4103/ijmr.IJMR_1812_15] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Milgrom DP, Maluccio MA, Koniaris LG. Management of Hepatocellular Carcinoma (HCC). Curr Surg Rep 2016;4. [DOI: 10.1007/s40137-016-0143-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
174 Iida H, Aihara T, Ikuta S, Yamanaka N. Comparative study of percutaneous radiofrequency ablation and hepatic resection for small, poorly differentiated hepatocellular carcinomas: RFA or resection for poorly differentiated HCC. Hepatol Res 2014;44:E156-62. [DOI: 10.1111/hepr.12264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
175 Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol. 2008;190:1544-1551. [PMID: 18492905 DOI: 10.2214/ajr.07.2798] [Cited by in Crossref: 65] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
176 Mizumoto M, Tokuuye K, Sugahara S, Nakayama H, Fukumitsu N, Ohara K, Abei M, Shoda J, Tohno E, Minami M. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. Int J Radiat Oncol Biol Phys. 2008;71:462-467. [PMID: 18243571 DOI: 10.1016/j.ijrobp.2007.09.056] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 5.1] [Reference Citation Analysis]
177 Clasen S, Krober SM, Kosan B, Aebert H, Fend F, Bomches A, Claussen CD, Pereira PL. Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer 2008;113:3121-9. [PMID: 18973180 DOI: 10.1002/cncr.23882] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
178 Hori M, Tanaka M, Ando E, Sakata M, Shimose S, Ohno M, Yutani S, Kuraoka K, Kuromatsu R, Sumie S, Sata M. Long-term outcome of elderly patients (75 years or older) with hepatocellular carcinoma. Hepatol Res 2014;44:975-82. [PMID: 24256493 DOI: 10.1111/hepr.12279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
179 Zheng L, Zhang Z, Wang Z, Bao K, Yang L, Yan B, Yan Z, Ye W, Yang R. A multiple closed-loops robotic calibration for accurate surgical puncture. Int J Med Robot 2021;17:e2242. [PMID: 33591646 DOI: 10.1002/rcs.2242] [Reference Citation Analysis]
180 Peng ZW, Zhang YJ, Liang HH, Lin XJ, Guo RP, Chen MS. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Radiology 2012;262:689-700. [PMID: 22157201 DOI: 10.1148/radiol.11110637] [Cited by in Crossref: 107] [Cited by in F6Publishing: 108] [Article Influence: 9.7] [Reference Citation Analysis]
181 Toya R, Murakami R, Baba Y, Nishimura R, Morishita S, Ikeda O, Kawanaka K, Beppu T, Sugiyama S, Sakamoto T, Yamashita Y, Oya N. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol. 2007;84:266-271. [PMID: 17716760 DOI: 10.1016/j.radonc.2007.07.005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
182 Mahnken AH, Bruners P, Günther RW. Techniques of interventional tumor therapy. Dtsch Arztebl Int 2008;105:646-53. [PMID: 19471636 DOI: 10.3238/arztebl.2008.0646] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
183 Ishikawa T, Imai M, Ko M, Sato H, Nozawa Y, Sano T, Iwanaga A, Seki K, Honma T, Yoshida T. Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm. Mol Clin Oncol 2017;7:61-6. [PMID: 28685077 DOI: 10.3892/mco.2017.1257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
184 Yoshimoto T, Kotoh K, Horikawa Y, Kohjima M, Morizono S, Yamashita S, Enjoji M, Nakamuta M. Decreased portal flow volume increases the area of necrosis caused by radio frequency ablation in pigs. Liver Int 2007;27:368-72. [DOI: 10.1111/j.1478-3231.2007.01454.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
185 Liu DS, Frampton AE. Plasma extracellular vesicles contain unannotated small RNA clusters suitable as biomarkers for detecting early hepatocellular carcinoma. Gut 2021:gutjnl-2021-325798. [PMID: 34799372 DOI: 10.1136/gutjnl-2021-325798] [Reference Citation Analysis]
186 Livraghi T. Single HCC smaller than 2 cm: surgery or ablation: interventional oncologist’s perspective. J Hepatobiliary Pancreat Sci. 2010;17:425-429. [PMID: 19890600 DOI: 10.1007/s00534-009-0244-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
187 Sato M, Tateishi R, Yasunaga H, Matsui H, Fushimi K, Ikeda H, Yatomi Y, Koike K. Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma. BJS Open 2017;1:50-4. [PMID: 29951606 DOI: 10.1002/bjs5.9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
188 Chen PY, Tsai TJ, Yang HY, Chou CK, Chang LJ, Chen TH, Hsu MT, Fang CC, Su CC, Lin YL, Feng YM, Chen CY. The Incidence of Bacteremia and Risk Factors of Post-Radiofrequency Ablation Fever for Patients with Hepato-Cellular Carcinoma. Cancers (Basel) 2021;13:5303. [PMID: 34771466 DOI: 10.3390/cancers13215303] [Reference Citation Analysis]
189 Chen S, Wang H, Zhang W, Chen J, Lu P. [Clinical application of laparoscopy-assisted and percutaneous radiofrequency ablation for hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao 2018;38:1147-50. [PMID: 30377101 DOI: 10.12122/j.issn.1673-4254.2018.09.21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Yin X, Zhang L, Wang YH, Zhang BH, Gan YH, Ge NL, Chen Y, Li LX, Ren ZG. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer. 2014;14:849. [PMID: 25409554 DOI: 10.1186/1471-2407-14-849] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
191 Yoshida H, Yoshida H, Shiina S, Omata M. Early liver cancer: concepts, diagnosis, and management. Int J Clin Oncol 2005;10:384-90. [DOI: 10.1007/s10147-005-0537-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
192 Mertyna P, Hines-Peralta A, Liu ZJ, Halpern E, Goldberg W, Goldberg SN. Radiofrequency ablation: variability in heat sensitivity in tumors and tissues. J Vasc Interv Radiol 2007;18:647-54. [PMID: 17494847 DOI: 10.1016/j.jvir.2007.02.033] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
193 Tseng H, Liu W, Tyan Y, Chiang H, Kuo W, Chou F. Sensitizing effect of 3-methyladenine on radiation-induced cytotoxicity in radio-resistant HepG2 cells in vitro and in tumor xenografts. Chemico-Biological Interactions 2011;192:201-8. [DOI: 10.1016/j.cbi.2011.03.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
194 Harada N, Hiramatsu N, Oze T, Tatsumi T, Hayashi N, Takehara T. Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma-A retrospective multicenter study: PegIFN/RBV Therapy After HCC Treatment. J Med Virol 2015;87:1199-206. [DOI: 10.1002/jmv.24173] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
195 Kim HJ, Rhim H, Lee MW, Jeong WK. Measurement of Intrahepatic Pressure during Microwave Ablation in an Ex Vivo Bovine Liver Model. Gut Liver 2015;9:784-90. [PMID: 25963083 DOI: 10.5009/gnl14272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
196 Liu M, Huang GL, Xu M, Pan FS, Lu MD, Zheng KG, Kuang M, Xie XY. Percutaneous thermal ablation for the treatment of colorectal liver metastases and hepatocellular carcinoma: a comparison of local therapeutic efficacy. Int J Hyperthermia 2017;33:446-53. [PMID: 28044471 DOI: 10.1080/02656736.2017.1278622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
197 Lee JM, Han JK, Kim HC, Kim SH, Kim KW, Joo SM, Choi BI. Multiple-electrode radiofrequency ablation of in vivo porcine liver: comparative studies of consecutive monopolar, switching monopolar versus multipolar modes. Invest Radiol 2007;42:676-83. [PMID: 17984764 DOI: 10.1097/RLI.0b013e3180661aad] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
198 Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. Journal of Gastroenterology and Hepatology 2009;24:223-7. [DOI: 10.1111/j.1440-1746.2008.05596.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
199 Kao W, Chiou Y, Hung H, Su C, Chou Y, Huo T, Huang Y, Wu W, Lin H, Lee S, Wu J. Younger Hepatocellular Carcinoma Patients Have Better Prognosis After Percutaneous Radiofrequency Ablation Therapy. Journal of Clinical Gastroenterology 2012;46:62-70. [DOI: 10.1097/mcg.0b013e31822b36cc] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
200 Bryce K, Tsochatzis EA. Downstaging for hepatocellular cancer: harm or benefit? Transl Gastroenterol Hepatol. 2017;2:106. [PMID: 29354763 DOI: 10.21037/tgh.2017.11.18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
201 Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol. 2011;9:617-623.e1. [PMID: 21459158 DOI: 10.1016/j.cgh.2011.03.027] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 7.1] [Reference Citation Analysis]
202 Mori Y, Tamai H, Shingaki N, Moribata K, Shiraki T, Deguchi H, Ueda K, Enomoto S, Magari H, Inoue I. Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma. Hepatol Int. 2009;3:509-515. [PMID: 19669252 DOI: 10.1007/s12072-009-9131-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
203 Hines-Peralta A, Sukhatme V, Regan M, Signoretti S, Liu ZJ, Goldberg SN. Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models. Radiology 2006;240:82-9. [PMID: 16720872 DOI: 10.1148/radiol.2401050788] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
204 Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Am J Clin Oncol. 2008;31:311-316. [PMID: 18845987 DOI: 10.1097/coc.0b013e31815e4539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
205 Shagdarsuren B, Tamai H, Shingaki N, Mori Y, Maeshima S, Nuta J, Maeda Y, Moribata K, Niwa T, Deguchi H, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma. Journal of Ultrasound in Medicine 2016;35:1383-91. [DOI: 10.7863/ultra.15.08042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
206 Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Hepatic resection versus operative microwave ablation for single hepatocellular carcinoma ≤5 cm: A propensity score-matched analysis. Surgery 2019;166:254-62. [PMID: 31279438 DOI: 10.1016/j.surg.2019.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
207 Huber TC, Bochnakova T, Koethe Y, Park B, Farsad K. Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies. J Hepatocell Carcinoma 2021;8:1181-93. [PMID: 34589446 DOI: 10.2147/JHC.S268300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Wakamatsu T, Ogasawara S, Chiba T, Yokoyama M, Inoue M, Kanogawa N, Saito T, Suzuki E, Ooka Y, Tawada A, Yokosuka O. Impact of Radiofrequency Ablation-Induced Glisson's Capsule-Associated Complications in Patients with Hepatocellular Carcinoma. PLoS One 2017;12:e0170153. [PMID: 28099460 DOI: 10.1371/journal.pone.0170153] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
209 Haga Y, Chiba T, Ohira G, Kanai F, Yokota H, Motoyama T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Miyauchi H, Matubara H, Yokosuka O. Simultaneous resection of disseminated hepatocellular carcinoma and colon cancer. Case Rep Gastroenterol 2013;7:37-43. [PMID: 23467038 DOI: 10.1159/000346925] [Reference Citation Analysis]
210 Chen S, Peng Z, Xiao H, Lin M, Chen Z, Jiang C, Hu W, Xie X, Liu L, Peng B, Kuang M. Combined radiofrequency ablation and ethanol injection versus repeat hepatectomy for elderly patients with recurrent hepatocellular carcinoma after initial hepatic surgery. Int J Hyperthermia 2018;34:1029-37. [PMID: 28974113 DOI: 10.1080/02656736.2017.1387941] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
211 Tateishi R, Shiina S, Yoshida H, Teratani T, Obi S, Yamashiki N, Yoshida H, Akamatsu M, Kawabe T, Omata M. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology 2006;44:1518-27. [DOI: 10.1002/hep.21408] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 6.6] [Reference Citation Analysis]
212 Pan YX, Fu YZ, Hu DD, Long Q, Wang JC, Xi M, Liu SL, Xu L, Liu MZ, Chen MS, Zhang YJ. Stereotactic Body Radiotherapy vs. Radiofrequency Ablation in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis. Front Oncol. 2020;10:1639. [PMID: 33194569 DOI: 10.3389/fonc.2020.01639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
213 Kondo M, Ishizawa T, Enooku K, Tokuhara Y, Ohkawa R, Uranbileg B, Nakagawa H, Tateishi R, Yoshida H, Kokudo N. Increased serum autotaxin levels in hepatocellular carcinoma patients were caused by background liver fibrosis but not by carcinoma. Clin Chim Acta. 2014;433:128-134. [PMID: 24642343 DOI: 10.1016/j.cca.2014.03.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
214 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584-2596. [PMID: 21858539 DOI: 10.1007/s00330-011-2222-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 8.3] [Reference Citation Analysis]
215 Tateishi R, Shiina S, Akahane M, Sato J, Kondo Y, Masuzaki R, Nakagawa H, Asaoka Y, Goto T, Otomo K, Omata M, Yoshida H, Koike K. Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma. PLoS One 2013;8:e59040. [PMID: 23593129 DOI: 10.1371/journal.pone.0059040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
216 Nesher N, Haim MB, Pevni D, Kessler A, Paz Y. Ultrasound-Guided, Video-Assisted Transdiaphragmatic Radiofrequency Ablation for Primary Liver Malignancy or Metastatic Nodules. Innovations�(Phila) 2011;6:337-40. [DOI: 10.1097/imi.0b013e3182362738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
217 Kawamoto C, Yamauchi A, Baba Y, Kaneko K, Yakabi K. Measurement of intrahepatic pressure during radiofrequency ablation in porcine liver. J Gastroenterol 2010;45:435-42. [DOI: 10.1007/s00535-009-0156-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
218 Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2012;35:544-554. [PMID: 21739345 DOI: 10.1007/s00270-011-0224-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
219 Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y, Hasegawa S, Tsubouchi H;  Kagoshima Liver Cancer Study Group. Surgical resection vs radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg. 2009;16:359-366. [PMID: 19300896 DOI: 10.1007/s00534-009-0069-7] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 6.8] [Reference Citation Analysis]
220 Teraoka Y, Kimura T, Aikata H, Daijo K, Osawa M, Honda F, Nakamura Y, Morio K, Morio R, Hatooka M, Kobayashi T, Nakahara T, Murakami E, Nagaoki Y, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Nagata Y, Chayama K. Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma. Hepatol Res. 2018;48:193-204. [PMID: 28544062 DOI: 10.1111/hepr.12916] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
221 Pompili M, Nicolardi E, Abbate V, Miele L, Riccardi L, Covino M, Matthaeis ND, Grieco A, Landolfi R, Rapaccini GL. Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol 2011; 17(26): 3126-3132 [PMID: 21912455 DOI: 10.3748/wjg.v17.i26.3126] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
222 Zhong Y, Deng M, Li K, Xu R. Delayed bronchobiliary fistula and cholangiolithiasis following percutaneous radio frequency ablation for hepatocellular carcinoma. Exp Biol Med (Maywood) 2015;240:156-9. [PMID: 25135987 DOI: 10.1177/1535370214548997] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
223 Park Y, Kim YS, Rhim H, Lim HK, Choi D, Lee WJ. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression. AJR Am J Roentgenol. 2009;193:757-763. [PMID: 19696290 DOI: 10.2214/ajr.08.2202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
224 Cho YK, Wook Chung J, Kim Y, Je Cho H, Hyun Yang S. Radiofrequency ablation of high-grade dysplastic nodules. Hepatology 2011;54:2005-11. [DOI: 10.1002/hep.24589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
225 Tsai M, Wang J, Hung C, Kee K, Yen Y, Lee C, Hu T, Chen C, Lu S. Favorable α-fetoprotein decrease as a prognostic surrogate in patients with hepatocellular carcinoma after radiofrequency ablation: α-Fetoprotein after radiofrequency ablation. Journal of Gastroenterology and Hepatology 2010;25:605-12. [DOI: 10.1111/j.1440-1746.2009.06115.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
226 Kwon H, Kim PN, Byun JH, Kim KW, Won HJ, Shin YM, Lee M. Various complications of percutaneous radiofrequency ablation for hepatic tumors: radiologic findings and technical tips. Acta Radiol 2014;55:1082-92. [DOI: 10.1177/0284185113513893] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
227 Fu XD, Liu YL. Relationship between postoperative imaging findings and therapeutic effect in patients with unresectable hepatocellular carcinoma after ultrasound-guided percutaneous radiofrequency ablation. Shijie Huaren Xiaohua Zazhi 2013; 21(33): 3747-3751 [DOI: 10.11569/wcjd.v21.i33.3747] [Reference Citation Analysis]
228 Portolani N, Baiocchi GL, Coniglio A, Grazioli L, Frassi E, Gheza F, Giulini SM. Sequential multidisciplinary treatment of hepatocellular carcinoma: the role of surgery as rescue therapy for failure of percutaneous ablation therapies. J Surg Oncol. 2009;100:580-584. [PMID: 19697354 DOI: 10.1002/jso.21375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
229 Nakagomi R, Tateishi R, Mikami S, Wake T, Kinoshita MN, Nakatsuka T, Minami T, Sato M, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Shiina S, Koike K. Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics. PLoS One 2021;16:e0259641. [PMID: 34797828 DOI: 10.1371/journal.pone.0259641] [Reference Citation Analysis]
230 Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Efficacy of surgical microwave ablation for recurrent hepatocellular carcinoma after curative hepatectomy. HPB 2020;22:461-9. [DOI: 10.1016/j.hpb.2019.08.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
231 Pereira PL, Masala S; Cardiovascular and Interventional Radiological Society of Europe (CIRSE). Standards of practice: guidelines for thermal ablation of primary and secondary lung tumors. Cardiovasc Intervent Radiol 2012;35:247-54. [PMID: 22271076 DOI: 10.1007/s00270-012-0340-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
232 Narsinh KH, Duncan DP, Newton IG, Minocha J, Rose SC. Liver-directed therapy for hepatocellular carcinoma. Abdom Radiol (NY). 2018;43:203-217. [PMID: 29230556 DOI: 10.1007/s00261-017-1435-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
233 Ioannou GN, Perkins JD, Carithers RL. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology. 2008;134:1342-1351. [PMID: 18471511 DOI: 10.1053/j.gastro.2008.02.013] [Cited by in Crossref: 193] [Cited by in F6Publishing: 178] [Article Influence: 13.8] [Reference Citation Analysis]
234 Clasen S, Rempp H, Pereira PL. [Metastases of colorectal carcinoma]. Radiologe 2008;48:1032-42. [PMID: 18953521 DOI: 10.1007/s00117-008-1706-x] [Reference Citation Analysis]
235 Yin X, Lu M. Percutaneous ablation for small hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;3:121-30. [DOI: 10.1586/egh.09.7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
236 Atri M, Alrashed A, Hassan A, Khalili K, Kim TK, Jang HJ. Negative Predictive Value of Contrast-Enhanced Ultrasound of Liver and Kidney Thermal Ablation Sites for Local Tumour Progression During Long-term Follow-up: A Retrospective Consecutive Study. Can Assoc Radiol J 2019;70:434-40. [PMID: 31585824 DOI: 10.1016/j.carj.2019.06.011] [Reference Citation Analysis]
237 Waghray A, Murali AR, Menon KN. Hepatocellular carcinoma: From diagnosis to treatment. World J Hepatol 2015; 7(8): 1020-1029 [PMID: 26052391 DOI: 10.4254/wjh.v7.i8.1020] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 11.6] [Reference Citation Analysis]
238 Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247:311-330. [PMID: 18430871 DOI: 10.1148/radiol.2472061331] [Cited by in Crossref: 274] [Cited by in F6Publishing: 233] [Article Influence: 19.6] [Reference Citation Analysis]
239 Okubo H, Kokubu S, Komiyama M, Yamagata H, Uchiyama A, Miyazaki A, Watanabe S. Radiofrequency ablation of hepatocellular carcinoma: The feasibility of magnetic resonance imaging with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid for evaluating the ablative margin: Gd-EOB-DTPA for ablative margin of liver ablation. Hepatology Research 2010;40:1034-41. [DOI: 10.1111/j.1872-034x.2010.00709.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
240 Dionisi F, Ben-josef E. The Use of Proton Therapy in the Treatment of Gastrointestinal Cancers: Liver. The Cancer Journal 2014;20:371-7. [DOI: 10.1097/ppo.0000000000000082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
241 Koizumi Y, Hirooka M, Ochi H, Tokumoto Y, Takechi M, Hiraoka A, Ikeda Y, Kumagi T, Matsuura B, Abe M, Hiasa Y. Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Med Ultrasonics 2015;42:185-93. [DOI: 10.1007/s10396-014-0598-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
242 Snowberger N, Chinnakotla S, Lepe RM, Peattie J, Goldstein R, Klintmalm GB, Davis GL. Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol Ther. 2007;26:1187-1194. [PMID: 17944733 DOI: 10.1111/j.1365-2036.2007.03498.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
243 Minami Y, Kudo M. Hepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage. Dig Dis. 2012;30:592-597. [PMID: 23258100 DOI: 10.1159/000343087] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
244 Lencioni R, Crocetti L. Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:181-194. [PMID: 22941021 DOI: 10.1007/978-3-642-16037-0_12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
245 Seror O, N’kontchou G, Muhammad M, Barrucand C, Tin Tin Htar M, Assaban M, Haddar D, Trinchet J, Beaugrand M, Sellier N. Influence de la proximité des gros vaisseaux sur les résultats du traitement des carcinomes hépato-cellulaires par radiofréquence : une étude contrôlée. Journal de Radiologie 2007;88:1157-64. [DOI: 10.1016/s0221-0363(07)89927-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
246 Guo F, Hu B, Chen L, Li J. Clinical application of contrast-enhanced ultrasound after percutaneous renal tumor ablation. Br J Radiol 2019;92:20190183. [PMID: 31509441 DOI: 10.1259/bjr.20190183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
247 Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up: Percutaneous RFA for small HCC. Journal of Gastroenterology and Hepatology 2010;25:597-604. [DOI: 10.1111/j.1440-1746.2009.06125.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
248 Yin X, Xie X, Lu M, Xu H, Xu Z, Kuang M, Liu G, Liang J, Lau WY. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: Long-term outcome and prognostic factors. Cancer 2009;115:1914-23. [DOI: 10.1002/cncr.24196] [Cited by in Crossref: 100] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
249 Kim JM, Kang TW, Kwon CHD, Joh JW, Ko JS, Park JB, Rhim H, Lee JH, Kim SJ, Paik SW. Single hepatocellular carcinoma ≤ 3 cm in left lateral segment: Liver resection or radiofrequency ablation? World J Gastroenterol 2014; 20(14): 4059-4065 [PMID: 24744596 DOI: 10.3748/wjg.v20.i14.4059] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
250 Lermite É, Aubé C, Pessaux P, Arnaud J. Thermo-ablation par radiofréquence des tumeurs hépatiques. La Presse Médicale 2007;36:1127-34. [DOI: 10.1016/j.lpm.2006.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
251 Liu Y, Lu L, Jin H, Chen X, Zhang Z, Liu Z, Liang C. Radiofrequency ablation of liver VX2 tumor: experimental results with MR diffusion-weighted imaging at 3.0T. PLoS One. 2014;9:e104239. [PMID: 25102074 DOI: 10.1371/journal.pone.0104239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
252 Wang K, Liu G, Li J, Yan Z, Xia Y, Wan X, Ji Y, Lau WY, Wu M, Shen F. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study. Eur J Surg Oncol 2015;41:236-42. [PMID: 25434327 DOI: 10.1016/j.ejso.2014.11.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
253 Zuo CH, Qiu XX, Ouyang YZ, Zhang D, Xiao H, Mo SC, Tan CQ, Tang M, Zhu HZ. Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma. Mol Clin Oncol. 2014;2:833-838. [PMID: 25054054 DOI: 10.3892/mco.2014.309] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
254 Delabrousse E, Mithieux F, Birer A, Chesnais S, Salomir R, Chapelon J, Lafon C. Percutaneous Sonographically Guided Interstitial US Ablation: Experimentation in an In Vivo Pig Liver Model. Journal of Vascular and Interventional Radiology 2008;19:1749-56. [DOI: 10.1016/j.jvir.2008.09.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
255 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 661] [Cited by in F6Publishing: 667] [Article Influence: 132.2] [Reference Citation Analysis]
256 Cha J, Choi D, Lee MW, Rhim H, Kim Y, Lim HK, Yoon JH, Park CK. Radiofrequency Ablation Zones in Ex Vivo Bovine and In Vivo Porcine Livers: Comparison of the Use of Internally Cooled Electrodes and Internally Cooled Wet Electrodes. Cardiovasc Intervent Radiol 2009;32:1235-40. [DOI: 10.1007/s00270-009-9600-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
257 Leen E, Horgan PG. Radiofrequency ablation of colorectal liver metastases. Surgical Oncology 2007;16:47-51. [DOI: 10.1016/j.suronc.2007.04.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
258 Hines-peralta AU, Pirani N, Clegg P, Cronin N, Ryan TP, Liu Z, Goldberg SN. Microwave Ablation: Results with a 2.45-GHz Applicator in ex Vivo Bovine and in Vivo Porcine Liver. Radiology 2006;239:94-102. [DOI: 10.1148/radiol.2383050262] [Cited by in Crossref: 117] [Cited by in F6Publishing: 96] [Article Influence: 7.3] [Reference Citation Analysis]
259 He N, Jin QN, Wang D, Yang YM, Liu YL, Wang GB, Tao KX. Radiofrequency ablation vs. hepatic resection for resectable colorectal liver metastases. J Huazhong Univ Sci Technolog Med Sci. 2016;36:514-518. [PMID: 27465325 DOI: 10.1007/s11596-016-1617-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
260 Forner A, Ayuso C, Isabel Real M, Sastre J, Robles R, Sangro B, Varela M, de la Mata M, Buti M, Martí-Bonmatí L, Bru C, Tabernero J, Llovet JM, Bruix J. [Diagnosis and treatment of hepatocellular carcinoma]. Med Clin (Barc) 2009;132:272-87. [PMID: 19248879 DOI: 10.1016/j.medcli.2008.11.024] [Cited by in Crossref: 56] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
261 Imamura H, Takami Y, Ryu T, Wada Y, Sasaki S, Ureshino H, Saitsu H. Feasibility and safety of surgical microwave ablation for hepatocellular carcinoma in elderly patients: a single center analysis in Japan. Sci Rep 2020;10:14215. [PMID: 32848193 DOI: 10.1038/s41598-020-71095-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
262 Kondo Y, Yoshida H, Tateishi R, Shiina S, Kawabe T, Omata M. Percutaneous radiofrequency ablation of liver cancer in the hepatic dome using the intrapleural fluid infusion technique. Br J Surg. 2008;95:996-1004. [PMID: 18581421 DOI: 10.1002/bjs.6058] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
263 Jiao D, Qian L, Zhang Y, Zhang F, Li C, Huang Z, Zhang L, Zhang W, Wu P, Han X. Microwave ablation treatment of liver cancer with 2,450-MHz cooled-shaft antenna: an experimental and clinical study. J Cancer Res Clin Oncol. 2010;136:1507-1516. [PMID: 20174824 DOI: 10.1007/s00432-010-0808-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
264 Zhang W, Luo E, Gan J, Song X, Bao Z, Zhang H, Chen M. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. World J Surg Oncol 2017;15:122. [PMID: 28679433 DOI: 10.1186/s12957-017-1189-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
265 Lau WY, Lau SHY. The current role of radiofrequency ablation in the treatment of hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2017;16:122-6. [DOI: 10.1016/s1499-3872(16)60182-0] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
266 Forner A, Vilana R, Bianchi L, Rodríguez-lope C, Reig M, García-criado MÁ, Rimola J, Solé M, Ayuso C, Bru C, Bruix J. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2cm. Journal of Hepatology 2015;62:150-5. [DOI: 10.1016/j.jhep.2014.08.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
267 Lee SD, Han HS, Cho JY, Yoon YS, Hwang DW, Jung K, Yoon CJ, Kwon Y, Kim JH. Safety and efficacy of laparoscopic radiofrequency ablation for hepatic malignancies. J Korean Surg Soc 2012;83:36-42. [PMID: 22792532 DOI: 10.4174/jkss.2012.83.1.36] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
268 Müller SA, Maier-hein L, Mehrabi A, Pianka F, Rietdorf U, Wolf I, Grenacher L, Richter G, Gutt CN, Schmidt J, Meinzer HP, Schmied BM. Creation and establishment of a respiratory liver motion simulator for liver interventions: Respiratory liver motion simulator. Med Phys 2007;34:4605-8. [DOI: 10.1118/1.2805475] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
269 Borys N, Dewhirst MW. Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery. Adv Drug Deliv Rev 2021;178:113985. [PMID: 34555486 DOI: 10.1016/j.addr.2021.113985] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
270 Abdelfattah AAM, Rizk F, Hawash N, Hanafy A, El-kalla F, Abd-elsalam S. Randomized trial of preoperative administration of oral pregabalin for postoperative analgesia in patients scheduled for radiofrequency ablation of focal lesions in the liver. International Journal of Hyperthermia 2018;34:1367-71. [DOI: 10.1080/02656736.2018.1424946] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
271 Moribata K, Tamai H, Shingaki N, Mori Y, Shiraki T, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Ichinose M. Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation. World J Hepatol 2012; 4(12): 374-381 [DOI: 10.4254/wjh.v4.i12.374] [Reference Citation Analysis]
272 Arciero CA, Sigurdson ER. Liver-directed therapies for patients with primary liver cancer and hepatic metastases. Curr Treat Options Oncol. 2006;7:399-409. [PMID: 16904057 DOI: 10.1007/s11864-006-0008-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
273 Kimura T, Aikata H, Takahashi S, Takahashi I, Nishibuchi I, Doi Y, Kenjo M, Murakami Y, Honda Y, Kakizawa H, Awai K, Chayama K, Nagata Y. Stereotactic body radiotherapy for patients with small hepatocellular carcinoma ineligible for resection or ablation therapies. Hepatol Res 2015;45:378-86. [PMID: 24849379 DOI: 10.1111/hepr.12359] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
274 Park MJ, Kim Y, Rhim H, Lim HK, Shin BS, Choi D, Lee MW, Kim DH. Prospective Analysis of the Pattern and Risk for Severe Vital Sign Changes During Percutaneous Radiofrequency Ablation of the Liver Under Opioid Analgesia. American Journal of Roentgenology 2010;194:799-808. [DOI: 10.2214/ajr.09.3044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
275 Fong Y, Wong J. Evolution in surgery: influence of minimally invasive approaches on the hepatobiliary surgeon. Surg Infect (Larchmt) 2009;10:399-406. [PMID: 19943774 DOI: 10.1089/sur.2009.9936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
276 Hiraoka A, Kumada T, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Koizumi Y, Nakamura S, Joko K, Iijima H, Hiasa Y, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (Hepatocellular Carcinoma Experts from 48 Clinics in Japan). Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience. Cancer Rep (Hoboken) 2022;5:e1464. [PMID: 34114752 DOI: 10.1002/cnr2.1464] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
277 Gómez Senent S, Gómez Raposo C, Segura Cabral JM. Guía para el diagnóstico, estadificación y tratamiento del hepatocarcinoma. Medicina Clínica 2007;128:741-8. [DOI: 10.1157/13106134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
278 Lin ZZ, Shau WY, Hsu C, Shao YY, Yeh YC, Kuo RN, Hsu CH, Yang JC, Cheng AL, Lai MS. Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size. PLoS One 2013;8:e80276. [PMID: 24244668 DOI: 10.1371/journal.pone.0080276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
279 Yoon DH, Shim JH, Lee WJ, Kim PN, Shin JH, Kim KM. Percutaneous management of a bronchobiliary fistula after radiofrequency ablation in a patient with hepatocellular carcinoma. Korean J Radiol. 2009;10:411-415. [PMID: 19568472 DOI: 10.3348/kjr.2009.10.4.411] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
280 Yan J, Zhang J, Wang M, Yuan K, Bai Y, Wang Y, Xin H, Wang Z, Liu F, Duan F, Fu J. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Asia-Pac J Clin Oncol 2018;14:300-9. [DOI: 10.1111/ajco.12817] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
281 Baba Y, Hayashi S, Ueno K, Nakajo M, Ueno S, Kubo F, Baba Y, Hamanoue M, Hasegawa S, Tsubouchi H, Komorizono Y. Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma. Oncol Lett 2010;1:905-11. [PMID: 22966404 DOI: 10.3892/ol_00000161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
282 Ryan MJ, Willatt J, Majdalany BS, Kielar AZ, Chong S, Ruma JA, Pandya A. Ablation techniques for primary and metastatic liver tumors. World J Hepatol 2016; 8(3): 191-199 [PMID: 26839642 DOI: 10.4254/wjh.v8.i3.191] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
283 Künzli BM, Abitabile P, Maurer CA. Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future. World J Hepatol 2011; 3(1): 8-14 [PMID: 21307982 DOI: 10.4254/wjh.v3.i1.8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 5.9] [Reference Citation Analysis]
284 Nishikawa H, Inuzuka T, Takeda H, Nakajima J, Sakamoto A, Henmi S, Matsuda F, Eso Y, Ishikawa T, Saito S. Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation. J Gastroenterol. 2011;46:1418-1426. [PMID: 21845378 DOI: 10.1007/s00535-011-0452-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
285 Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma). The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol 2014;4:S3-S26. [PMID: 25755608 DOI: 10.1016/j.jceh.2014.04.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
286 Dobbins C, Brennan C, Wemyss-Holden S, Cockburn J, Maddern G. Bimodal electric tissue ablation-long term studies of morbidity and pathological change. J Surg Res 2008;148:251-9. [PMID: 18395751 DOI: 10.1016/j.jss.2007.09.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
287 Kondo Y, Yoshida H, Shiina S, Tateishi R, Teratani T, Omata M. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract. British Journal of Surgery 2006;93:1277-82. [DOI: 10.1002/bjs.5374] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
288 Chiou SY, Liu JB, Needleman L. Current status of sonographically guided radiofrequency ablation techniques. J Ultrasound Med 2007;26:487-99. [PMID: 17384046 DOI: 10.7863/jum.2007.26.4.487] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
289 Ohki T, Tateishi R, Shiina S, Sato T, Masuzaki R, Yoshida H, Kanai F, Obi S, Yoshida H, Omata M. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma. Liver Int 2007;27:360-7. [DOI: 10.1111/j.1478-3231.2006.01420.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
290 Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Liver Int. 2013;33:884-893. [PMID: 23461618 DOI: 10.1111/liv.12132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
291 Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. J Gastroenterol Hepatol. 2010;25:403-407. [PMID: 19929922 DOI: 10.1111/j.1440-1746.2009.06037.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
292 Chen TM, Lin CC, Huang PT, Wen CF. Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation. J Gastroenterol Hepatol 2011;26:858-65. [PMID: 21251068 DOI: 10.1111/j.1440-1746.2011.06664.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
293 Fischbach F, Lohfink K, Gaffke G, Wybranski C, Mohnike K, Wonneberger U, Pech M, Jungnickel K, Ricke J, Strach K. Magnetic Resonance–Guided Freehand Radiofrequency Ablation of Malignant Liver Lesions: A New Simplified and Time-Efficient Approach Using an Interactive Open Magnetic Resonance Scan Platform and Hepatocyte-Specific Contrast Agent. Investigative Radiology 2013;48:422-8. [DOI: 10.1097/rli.0b013e3182803dae] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
294 Teng W, Jeng WJ, Chen WT, Lin CC, Lin CY, Lin SM, Sheen IS. Soluble form of CTLA-4 is a good predictor for tumor recurrence after radiofrequency ablation in hepatocellular carcinoma patients. Cancer Med 2022. [PMID: 35435327 DOI: 10.1002/cam4.4760] [Reference Citation Analysis]
295 Huang JW, Hernandez-Alejandro R, Croome KP, Yan LN, Wu H, Chen ZY, Prasoon P, Zeng Y. Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations. World J Gastroenterol 2011; 17(1): 123-129 [PMID: 21218093 DOI: 10.3748/wjg.v17.i1.123] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
296 Gervais DA, Goldberg SN, Brown DB, Soulen MC, Millward SF, Rajan DK. Society of Interventional Radiology position statement on percutaneous radiofrequency ablation for the treatment of liver tumors. J Vasc Interv Radiol. 2009;20:S342-S347. [PMID: 19560023 DOI: 10.1016/j.jvir.2009.04.029] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
297 Redolfi Riva E, Desii A, Sinibaldi E, Ciofani G, Piazza V, Mazzolai B, Mattoli V. Gold nanoshell/polysaccharide nanofilm for controlled laser-assisted tissue thermal ablation. ACS Nano 2014;8:5552-63. [PMID: 24797875 DOI: 10.1021/nn406348v] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
298 Takami Y, Ryu T, Wada Y, Saitsu H. Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases. J Hepatobiliary Pancreat Sci 2013;20:332-41. [PMID: 22710886 DOI: 10.1007/s00534-012-0527-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
299 Lundt JE, Allen SP, Shi J, Hall TL, Cain CA, Xu Z. Non-invasive, Rapid Ablation of Tissue Volume Using Histotripsy. Ultrasound Med Biol 2017;43:2834-47. [PMID: 28935135 DOI: 10.1016/j.ultrasmedbio.2017.08.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
300 Cua IH, Lin CC, Lin CJ, Chen WT, Hsu CW, Chen YC, Wong SN, Lin SM. Treatment of hepatocellular carcinoma using internally cooled electrodes. A prospective comparison of modified automated vs. manual pulsed radiofrequency algorithms. Oncology 2007;72 Suppl 1:76-82. [PMID: 18087186 DOI: 10.1159/000111711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
301 Lencioni R, Crocetti L. Radiofrequency Ablation of Liver Cancer. Techniques in Vascular and Interventional Radiology 2007;10:38-46. [DOI: 10.1053/j.tvir.2007.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
302 Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK. Planning Sonography to Assess the Feasibility of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas. American Journal of Roentgenology 2008;190:1324-30. [DOI: 10.2214/ajr.07.2970] [Cited by in Crossref: 72] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
303 Rhim H, Lim HK, Kim Y, Choi D. Percutaneous Radiofrequency Ablation with Artificial Ascites for Hepatocellular Carcinoma in the Hepatic Dome: Initial Experience. American Journal of Roentgenology 2008;190:91-8. [DOI: 10.2214/ajr.07.2384] [Cited by in Crossref: 99] [Cited by in F6Publishing: 41] [Article Influence: 7.1] [Reference Citation Analysis]
304 Kuo Y, Chung K, Hung C, Lu S, Wang J. The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma. The Kaohsiung Journal of Medical Sciences 2014;30:559-65. [DOI: 10.1016/j.kjms.2014.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
305 Kim JW, Shin JH, Kim PN, Shin YM, Won HJ, Ko GY, Yoon HK. Embolization for Bleeding after Hepatic Radiofrequency Ablation. J Vasc Interv Radiol 2017;28:356-365.e2. [PMID: 28012690 DOI: 10.1016/j.jvir.2016.09.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
306 Sugino Y, Yamakado K, Yamanaka T, Fujimori M, Nakatsuka A, Takaki H, Takei Y, Sakuma H, Isaji S. Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma. Jpn J Radiol 2017;35:254-61. [PMID: 28357723 DOI: 10.1007/s11604-017-0628-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
307 Hiraoka A, Kumada T, Tsuji K, Takaguchi K, Itobayashi E, Kariyama K, Ochi H, Tajiri K, Hirooka M, Shimada N, Ishikawa T, Tachi Y, Tada T, Toyoda H, Nouso K, Joko K, Hiasa Y, Michitaka K, Kudo M. Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis. Liver Cancer 2019;8:121-9. [PMID: 31019902 DOI: 10.1159/000488778] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 11.3] [Reference Citation Analysis]
308 Pugalenthi A, Cutter CS, Fong Y. Current treatment for small (< 5 cm) hepatocellular carcinoma: evolving roles for ablation and resection. Adv Surg 2014;48:97-114. [PMID: 25293610 DOI: 10.1016/j.yasu.2014.05.012] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
309 Hatzaras I, Bischof DA, Fahy B, Cosgrove D, Pawlik TM. Treatment options and surveillance strategies after therapy for hepatocellular carcinoma. Ann Surg Oncol 2014;21:758-66. [PMID: 24006095 DOI: 10.1245/s10434-013-3254-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
310 Mertyna P, Goldberg W, Yang W, Goldberg SN. Thermal ablation a comparison of thermal dose required for radiofrequency-, microwave-, and laser-induced coagulation in an ex vivo bovine liver model. Acad Radiol. 2009;16:1539-1548. [PMID: 19836267 DOI: 10.1016/j.acra.2009.06.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
311 Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-26. [PMID: 18331969 DOI: 10.1102/1470-7330.2008.0004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
312 Xi XJ, Zhang Y, Yin YH, Li H, Ma DD, Qu YQ. Bronchobiliary fistula following radiofrequency ablation for liver metastases from breast cancer: A case report and literature review. Medicine (Baltimore) 2018;97:e12760. [PMID: 30412067 DOI: 10.1097/MD.0000000000012760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
313 Clasen S, Rempp H, Boss A, Schmidt D, Fritz J, Schraml C, Schick F, Claussen CD, Pereira PL. MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness. J Vasc Interv Radiol 2011;22:762-70. [PMID: 21530311 DOI: 10.1016/j.jvir.2011.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
314 Lahbabi M, N'kontchou G, Aout M, Vicaud E, Ganne N, Trinchet JC, Seror O, Beaugrand M. [Results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over]. Rev Med Interne 2012;33:128-33. [PMID: 22226387 DOI: 10.1016/j.revmed.2011.12.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
315 Hidaka H, Kokubu S, Nakazawa T, Minamino T, Takada J, Tanaka Y, Okuwaki Y, Watanabe M, Shibuya A, Saigenji K. Therapeutic benefits of partial splenic embolization for thrombocytopenia in hepatocellular carcinoma patients treated with radiofrequency ablation. Hepatol Res. 2009;39:772-778. [PMID: 19473438 DOI: 10.1111/j.1872-034x.2009.00508.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
316 Venkatesan AM, Gervais DA, Mueller PR. Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: current concepts and review of the literature. Semin Intervent Radiol. 2006;23:73-84. [PMID: 21326722 DOI: 10.1055/s-2006-939843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
317 Delicque J, Boulin M, Guiu B, Pelage J, Escal L, Schembri V, Assenat E, Fohlen A. Interventional oncology for hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2016;40:530-7. [DOI: 10.1016/j.clinre.2016.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
318 . Bringing Research to Clinical Application. In: Hillery AM, Park K, editors. Drug Delivery. Taylor & Francis Group: CRC Press; 2016. pp. 523-85. [DOI: 10.1201/9781315382579-24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
319 Terraz S, Constantin C, Majno PE, Spahr L, Mentha G, Becker CD. Image-guided multipolar radiofrequency ablation of liver tumours: initial clinical results. Eur Radiol 2007;17:2253-61. [DOI: 10.1007/s00330-007-0626-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
320 Wiggermann P, Puls R, Vasilj A, Sieroń D, Schreyer AG, Jung EM, Wawrzynek W, Stroszczynski C. Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival. Med Sci Monit 2012;18:CR88-92. [PMID: 22293882 DOI: 10.12659/msm.882463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
321 Satiya J, Schwartz I, Tabibian JH, Kumar V, Girotra M. Ablative therapies for hepatic and biliary tumors: endohepatology coming of age. Transl Gastroenterol Hepatol 2020;5:15. [PMID: 32258519 DOI: 10.21037/tgh.2019.10.17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
322 Sawada T, Kubota K, Kita J, Kato M, Shiraki T, Park K, Shimoda M. Clinical outcome of hepatectomy for hepatocellular carcinomas≤2 cm. World J Surg 2011;35:377-85. [PMID: 21042908 DOI: 10.1007/s00268-010-0851-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
323 Lencioni R, Della Pina C, Crocetti L, Cioni D. Percutaneous Ablation of Hepatocellular Carcinoma. In: Stroszczynski C, editor. Minimally Invasive Tumor Therapies. Berlin: Springer Berlin Heidelberg; 2006. pp. 91-105. [DOI: 10.1007/3-540-28137-1_7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
324 Hata M, Tokuuye K, Sugahara S, Fukumitsu N, Hashimoto T, Ohnishi K, Nemoto K, Ohara K, Matsuzaki Y, Akine Y. Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer 2006;107:591-8. [PMID: 16804931 DOI: 10.1002/cncr.22039] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
325 Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010; 2(4): 128-136 [PMID: 21160861 DOI: 10.4240/wjgs.v2.i4.128] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
326 Wu WC, Chiou YY, Hung HH, Kao WY, Chou YH, Su CW, Wu JC, Huo TI, Huang YH, Lee KC. Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation. J Clin Gastroenterol. 2012;46:789-795. [PMID: 22941428 DOI: 10.1097/mcg.0b013e31825ceeb5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
327 Chen X, Chen Y, Li Q, Ma D, Shen B, Peng C. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis. Journal of Surgical Research 2015;195:166-74. [DOI: 10.1016/j.jss.2015.01.042] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
328 Bhardwaj N, Strickland AD, Ahmad F, Dennison AR, Lloyd DM. Liver ablation techniques: a review. Surg Endosc. 2010;24:254-265. [PMID: 19554370 DOI: 10.1007/s00464-009-0590-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
329 Piscaglia F, Leoni S, Cabibbo G, Borghi A, Imbriaco G, Golfieri R, Bolondi L. Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. Digestive and Liver Disease 2010;42:729-34. [DOI: 10.1016/j.dld.2010.03.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
330 Pan YX, Xi M, Fu YZ, Hu DD, Wang JC, Liu SL, Chen JB, Xu L, Zhou ZG, Liu MZ, Chen MS, Zhao L, Zhang YJ. Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study. Cancers (Basel) 2019;11:E1116. [PMID: 31387248 DOI: 10.3390/cancers11081116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
331 Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252:903-912. [PMID: 21107100 DOI: 10.1097/sla.0b013e3181efc656] [Cited by in Crossref: 469] [Cited by in F6Publishing: 210] [Article Influence: 39.1] [Reference Citation Analysis]
332 Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, Mine N, Kondo Y, Kawabe T, Omata M. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43:1101-1108. [PMID: 16628706 DOI: 10.1002/hep.21164] [Cited by in Crossref: 217] [Cited by in F6Publishing: 200] [Article Influence: 13.6] [Reference Citation Analysis]
333 Sakamaki A, Watanabe T, Abe S, Kamimura K, Tsuchiya A, Takamura M, Kawai H, Yamagiwa S, Terai S. Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient. Clin J Gastroenterol 2017;10:261-4. [PMID: 28324272 DOI: 10.1007/s12328-017-0735-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
334 Uehara T, Hirooka M, Ishida K, Hiraoka A, Kumagi T, Kisaka Y, Hiasa Y, Onji M. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites. J Gastroenterol. 2007;42:306-311. [PMID: 17464460 DOI: 10.1007/s00535-006-1949-0] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.0] [Reference Citation Analysis]
335 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
336 Kluger MD, Cherqui D. Laparoscopic resection of hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:111-126. [PMID: 22941017 DOI: 10.1007/978-3-642-16037-0_8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
337 Abbadessa G, Rimassa L, Pressiani T, Carrillo-Infante C, Cucchi E, Santoro A. Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib. World J Gastroenterol 2011; 17(19): 2450-2453 [PMID: 21633647 DOI: 10.3748/wjg.v17.i19.2450] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
338 Motoyama T, Ogasawara S, Chiba T, Higashide T, Yokota H, Kanogawa N, Suzuki E, Ooka Y, Tawada A, Irie R, Ochi S, Masuda Y, Uno T, Yokosuka O. Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Abdom Imaging 2014;39:262-8. [DOI: 10.1007/s00261-013-0054-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
339 Terashima T, Yamashita T, Arai K, Sunagozaka H, Kitahara M, Nakagawa H, Kagaya T, Mizukoshi E, Honda M, Kaneko S. Feasibility and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma after sorafenib. Hepatol Res 2014;44:1179-85. [PMID: 24171787 DOI: 10.1111/hepr.12266] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
340 Hyun D, Cho SK, Shin SW, Rhim H, Koh KC, Paik SW. Treatment of Small Hepatocellular Carcinoma (≤ 2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation. Cardiovasc Intervent Radiol. 2016;39:1015-1022. [PMID: 26975761 DOI: 10.1007/s00270-016-1314-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
341 Mukund A, Vats P, Jindal A, Patidar Y, Sarin SK. Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes. J Clin Exp Hepatol. 2020;10:563-573. [PMID: 33311893 DOI: 10.1016/j.jceh.2020.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
342 Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ohkawa A. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2012;82:e529-e535. [PMID: 22284041 DOI: 10.1016/j.ijrobp.2011.05.056] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
343 Cheung TT, Ma KW, She WH. A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr 2021;10:193-209. [PMID: 33898560 DOI: 10.21037/hbsn.2020.03.11] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Yu H, Burke CT. Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors. Semin Intervent Radiol. 2014;31:129-137. [PMID: 25071303 DOI: 10.1055/s-0034-1373788] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
345 Shiina S, Sato K, Tateishi R, Shimizu M, Ohama H, Hatanaka T, Takawa M, Nagamatsu H, Imai Y. Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery. Can J Gastroenterol Hepatol 2018;2018:4756147. [PMID: 29974040 DOI: 10.1155/2018/4756147] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
346 Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2016;31:1031-1036. [PMID: 26647219 DOI: 10.1111/jgh.13250] [Cited by in Crossref: 109] [Cited by in F6Publishing: 110] [Article Influence: 21.8] [Reference Citation Analysis]
347 Tanaka T, Isfort P, Bruners P, Penzkofer T, Kichikawa K, Schmitz-Rode T, Mahnken AH. Optimization of direct current-enhanced radiofrequency ablation: an ex vivo study. Cardiovasc Intervent Radiol 2010;33:1028-32. [PMID: 20094718 DOI: 10.1007/s00270-010-9797-y] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
348 Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Korean J Hepatol. 2009;15:474-485. [PMID: 20037266 DOI: 10.3350/kjhep.2009.15.4.474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
349 Gillams A. Tumour ablation: current role in the liver, kidney, lung and bone. Cancer Imaging. 2008;8 Spec No A:S1-S5. [PMID: 18852074 DOI: 10.1102/1470-7330.2008.9001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
350 Bianchi L, Korganbayev S, Orrico A, De Landro M, Saccomandi P. Quasi-distributed fiber optic sensor-based control system for interstitial laser ablation of tissue: theoretical and experimental investigations. Biomed Opt Express 2021;12:2841-58. [PMID: 34168905 DOI: 10.1364/BOE.419541] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
351 Rhim H, Lim HK, Kim YS, Choi D, Lee WJ. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol. 2008;23:1492-1500. [PMID: 18713294 DOI: 10.1111/j.1440-1746.2008.05550.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
352 Choi JW, Lee JM, Lee DH, Yoon JH, Kim YJ, Lee JH, Yu SJ, Cho EJ. Radiofrequency Ablation Using a Separable Clustered Electrode for the Treatment of Hepatocellular Carcinomas: A Randomized Controlled Trial of a Dual-Switching Monopolar Mode Versus a Single-Switching Monopolar Mode. Korean J Radiol 2021;22:179-88. [PMID: 32729269 DOI: 10.3348/kjr.2020.0134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
353 Yoshida H, Yoshida H, Goto E, Sato T, Ohki T, Masuzaki R, Tateishi R, Goto T, Shiina S, Kawabe T. Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma. Hepatol Int. 2008;2:89-94. [PMID: 19669283 DOI: 10.1007/s12072-007-9020-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
354 Tang Z, Fang H, Kang M, Zhang B, Dong X, Chen X, Xu J, Chen J, Wu Y. Percutaneous radiofrequency ablation for liver tumors: Is it safer and more effective in low-risk areas than in high-risk areas? Hepatol Res 2011;41:635-40. [PMID: 21711422 DOI: 10.1111/j.1872-034X.2011.00817.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
355 Liapi E, Geschwind JF. Transcatheter and ablative therapeutic approaches for solid malignancies. J Clin Oncol. 2007;25:978-986. [PMID: 17350947 DOI: 10.1200/jco.2006.09.8657] [Cited by in Crossref: 129] [Cited by in F6Publishing: 55] [Article Influence: 8.6] [Reference Citation Analysis]
356 Sugo H, Ishizaki Y, Yoshimoto J, Imamura H, Kawasaki S. Salvage hepatectomy for local recurrent hepatocellular carcinoma after ablation therapy. Ann Surg Oncol. 2012;19:2238-2245. [PMID: 22302262 DOI: 10.1245/s10434-012-2220-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
357 Costanzo GGD, Francica G, Pacella CM. Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives. World J Hepatol 2014; 6(10): 704-715 [PMID: 25349642 DOI: 10.4254/wjh.v6.i10.704] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
358 Dai WC, Cheung TT. Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence. Expert Rev Anticancer Ther 2016;16:1063-72. [PMID: 27548586 DOI: 10.1080/14737140.2016.1226136] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
359 de Meijer VE, Verhoef C, Kuiper JW, Alwayn IP, Kazemier G, Ijzermans JN. Radiofrequency ablation in patients with primary and secondary hepatic malignancies. J Gastrointest Surg 2006;10:960-73. [PMID: 16843866 DOI: 10.1016/j.gassur.2006.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
360 Iida H, Aihara T, Ikuta S, Yamanaka N. Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping. World J Gastroenterol 2012; 18(41): 5870-5878 [PMID: 23139602 DOI: 10.3748/wjg.v18.i41.5870] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
361 Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Wu JC, Huo TI, Huang YH, Wu WC, Lin HC. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy. Clin Radiol. 2012;67:429-436. [PMID: 22153231 DOI: 10.1016/j.crad.2011.10.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
362 Schindera ST, Nelson RC, DeLong DM, Clary B. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. J Vasc Interv Radiol. 2006;17:1631-1637. [PMID: 17057005 DOI: 10.1097/01.rvi.0000239106.98853.b8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
363 Pregler B, Beyer LP, Wiesinger I, Haimerl M, Stroszczynski C, Jung EM, Wiggermann P. Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation. Clin Hemorheol Microcirc 2017;67:383-8. [PMID: 28885205 DOI: 10.3233/CH-179218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
364 Nishikawa H, Kimura T, Kita R, Osaki Y. Treatment for hepatocellular carcinoma in elderly patients: a literature review. J Cancer 2013;4:635-43. [PMID: 24155775 DOI: 10.7150/jca.7279] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
365 Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, Yang GY, Larson AC. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 2010;70:1555-63. [PMID: 20124486 DOI: 10.1158/0008-5472.CAN-09-3067] [Cited by in Crossref: 131] [Cited by in F6Publishing: 46] [Article Influence: 10.9] [Reference Citation Analysis]
366 Kooby DA, Egnatashvili V, Graiser M, Delman KA, Kauh J, Wood WC, Staley Iii CA. Changing management and outcome of hepatocellular carcinoma: Evaluation of 501 patients treated at a single comprehensive center: Liver Cancer. J Surg Oncol 2008;98:81-8. [DOI: 10.1002/jso.21049] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
367 Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer. 2010;116:3638-3644. [PMID: 20564097 DOI: 10.1002/cncr.25142] [Cited by in Crossref: 81] [Cited by in F6Publishing: 69] [Article Influence: 6.8] [Reference Citation Analysis]
368 Lin SM. Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer 2013;2:73-83. [PMID: 24159599 DOI: 10.1159/000343843] [Cited by in Crossref: 26] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
369 Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Pinna AD. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(26): 4106-4118 [PMID: 23864773 DOI: 10.3748/wjg.v19.i26.4106] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
370 Asaoka Y, Tateishi R, Nakagomi R, Kondo M, Fujiwara N, Minami T, Sato M, Uchino K, Enooku K, Nakagawa H. Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma. PLoS One. 2014;9:e111662. [PMID: 25397677 DOI: 10.1371/journal.pone.0111662] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
371 Littrup PJ, Jallad B, Vorugu V, Littrup G, Currier B, George M, Herring D. Lethal isotherms of cryoablation in a phantom study: effects of heat load, probe size, and number. J Vasc Interv Radiol 2009;20:1343-51. [PMID: 19695903 DOI: 10.1016/j.jvir.2009.05.038] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 6.2] [Reference Citation Analysis]
372 Fuke H, Sugimoto K, Shiraki K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Takaki H, Nakatsuka A. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization. Aliment Pharmacol Ther. 2008;27:1253-1260. [PMID: 18221404 DOI: 10.1111/j.1365-2036.2008.03627.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
373 Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS. Radiofrequency ablation vs hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology. 2012;262:1022-1033. [PMID: 22357902 DOI: 10.1148/radiol.11110817] [Cited by in Crossref: 141] [Cited by in F6Publishing: 130] [Article Influence: 14.1] [Reference Citation Analysis]
374 Akahane M, Koga H, Kato N, Yamada H, Uozumi K, Tateishi R, Teratani T, Shiina S, Ohtomo K. Complications of percutaneous radiofrequency ablation for hepato-cellular carcinoma: imaging spectrum and management. Radiographics. 2005;25 Suppl 1:S57-S68. [PMID: 16227497 DOI: 10.1148/rg.25si055505] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
375 Yu SJ, Kim YJ. Hepatitis B viral load affects prognosis of hepatocellular carcinoma. World J Gastroenterol 2014; 20(34): 12039-12044 [PMID: 25232241 DOI: 10.3748/wjg.v20.i34.12039] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
376 Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z, Prasoon P, Zeng Y. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases. J Gastrointest Surg. 2011;15:311-320. [PMID: 21052859 DOI: 10.1007/s11605-010-1372-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.3] [Reference Citation Analysis]
377 Guimaraes M, Uflacker R. Locoregional therapy for hepatocellular carcinoma. Clin Liver Dis 2011;15:395-421, vii-x. [PMID: 21689621 DOI: 10.1016/j.cld.2011.03.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
378 Fukuhara T, Aikata H, Hyogo H, Honda Y, Morio K, Morio R, Hatooka M, Kobayashi T, Naeshiro N, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Chayama K. Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases. Eur J Radiol 2015;84:1540-5. [PMID: 25979193 DOI: 10.1016/j.ejrad.2015.04.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
379 Matoba M, Tsuchiya H, Kondo T, Ota K. Stereotactic body radiotherapy delivered with IMRT for oligometastatic regional lymph node metastases in hepatocellular carcinoma: a single-institutional study. J Radiat Res. 2020;61:776-783. [PMID: 32845298 DOI: 10.1093/jrr/rraa067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
380 Borzio M, Dionigi E, Parisi G, Raguzzi I, Sacco R. Management of hepatocellular carcinoma in the elderly. World J Hepatol 2015; 7(11): 1521-1529 [PMID: 26085911 DOI: 10.4254/wjh.v7.i11.1521] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
381 Francoz C, Belghiti J, Durand F. Indications of liver transplantation in patients with complications of cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:175-190. [PMID: 17223504 DOI: 10.1016/j.bpg.2006.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
382 Seidensticker M, Schütte K, Seidensticker R, Mühlmann M, Schulz C. Multi-modal and sequential treatment of liver cancer and its impact on the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2020;48-49:101709. [PMID: 33317790 DOI: 10.1016/j.bpg.2020.101709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
383 Wake T, Tateishi R, Nakagomi R, Fujiwara N, Kinoshita MN, Nakatsuka T, Sato M, Minami T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Tanaka Y, Shiina S, Koike K. Ischemic complications after percutaneous radiofrequency ablation of liver tumors: Liver volume loss and recovery. Hepatol Res 2018;49:453-61. [DOI: 10.1111/hepr.13302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
384 Faroja M, Ahmed M, Appelbaum L, Ben-David E, Moussa M, Sosna J, Nissenbaum I, Goldberg SN. Irreversible electroporation ablation: is all the damage nonthermal? Radiology. 2013;266:462-470. [PMID: 23169795 DOI: 10.1148/radiol.12120609] [Cited by in Crossref: 143] [Cited by in F6Publishing: 126] [Article Influence: 14.3] [Reference Citation Analysis]
385 Shirai K, Tamai H, Shingaki N, Mori Y, Moribata K, Enomoto S, Deguchi H, Ueda K, Maekita T, Inoue I, Iguchi M, Yanaoka K, Oka M, Ichinose M. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma: Seeding after RFA for HCC. Hepatology Research 2011;41:738-45. [DOI: 10.1111/j.1872-034x.2011.00841.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
386 Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol 2008;23:e422-7. [PMID: 17944897 DOI: 10.1111/j.1440-1746.2007.05177.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
387 Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270:900-909. [PMID: 24475823 DOI: 10.1148/radiol.13130940] [Cited by in Crossref: 155] [Cited by in F6Publishing: 152] [Article Influence: 17.2] [Reference Citation Analysis]
388 D'Avola D, Granito A, de la Torre-Aláez M, Piscaglia F. The importance of liver functional reserve in the non-surgical treatment of Hepatocellular Carcinoma. J Hepatol 2021:S0168-8278(21)02185-1. [PMID: 34793869 DOI: 10.1016/j.jhep.2021.11.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011;53:136-147. [PMID: 20967759 DOI: 10.1002/hep.23965] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 8.8] [Reference Citation Analysis]
390 Zhang F, Wu G, Sun H, Ding J, Xia F, Li X, Ma K, Wang S, Bie P. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. Int J Hyperthermia 2014;30:471-9. [PMID: 25314335 DOI: 10.3109/02656736.2014.961042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
391 Meershoek P, van den Berg NS, Lutjeboer J, Burgmans MC, van der Meer RW, van Rijswijk CSP, van Oosterom MN, van Erkel AR, van Leeuwen FWB. Assessing the value of volume navigation during ultrasound-guided radiofrequency- and microwave-ablations of liver lesions. Eur J Radiol Open 2021;8:100367. [PMID: 34286051 DOI: 10.1016/j.ejro.2021.100367] [Reference Citation Analysis]
392 Netto GJ, Altrabulsi B, Katabi N, Martin P, Burt K, Levy M, Sanchez E, Watkins DL, Jennings L, Klintmalm G, Goldstein R. Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and 'TUNEL' study. Liver Int. 2006;26:746-751. [PMID: 16842333 DOI: 10.1111/j.1478-3231.2006.01278.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
393 Ohki T, Tateishi R, Akahane M, Mikami S, Sato M, Uchino K, Arano T, Enooku K, Kondo Y, Yamashiki N. CT with hepatic arterioportography as a pretreatment examination for hepatocellular carcinoma patients: a randomized controlled trial. Am J Gastroenterol. 2013;108:1305-1313. [PMID: 23629602 DOI: 10.1038/ajg.2013.109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
394 Uchino K, Tateishi R, Nakagomi R, Fujiwara N, Minami T, Sato M, Enooku K, Nakagawa H, Asaoka Y, Kondo Y, Shibahara J, Shiina S, Koike K. Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation. PLoS One 2018;13:e0200943. [PMID: 30044835 DOI: 10.1371/journal.pone.0200943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
395 Liu Z, Ahmed M, Gervais D, Humphries S, Goldberg SN. Computer Modeling of Factors that Affect the Minimum Safety Distance Required for Radiofrequency Ablation Near Adjacent Nontarget Structures. Journal of Vascular and Interventional Radiology 2008;19:1079-86. [DOI: 10.1016/j.jvir.2008.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
396 Kusakabe A, Nojiri S, Iio E, Matsuura K, Shinkai N, Miyaki T, Joh T. Case-control study of the RFA therapeutic effect of newly developed 4D US and conventional 2D US. J Med Ultrason (2001) 2013;40:39-46. [PMID: 27276923 DOI: 10.1007/s10396-012-0388-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
397 Weinberg BD, Patel RB, Wu H, Blanco E, Barnett CC, Exner AA, Saidel GM, Gao J. Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants. Med Biol Eng Comput 2008;46:1039-49. [PMID: 18523817 DOI: 10.1007/s11517-008-0354-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
398 Qiu S, Jiao LR. Improving detection combined with targeted therapy for small hepatocellular carcinoma. Ann Transl Med 2019;7:S4. [PMID: 31032285 DOI: 10.21037/atm.2019.01.19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
399 Perera RH, Krupka TM, Wu H, Traughber B, Dremann D, Broome AM, Exner AA. Role of Pluronic block copolymers in modulation of heat shock protein 70 expression. Int J Hyperthermia 2011;27:672-81. [PMID: 21992560 DOI: 10.3109/02656736.2011.608218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
400 Hagihara H, Nouso K, Kobayashi Y, Iwasaki Y, Nakamura S, Kuwaki K, Toshimori J, Miyatake H, Ohnishi H, Shiraha H, Yamamoto K. Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. Int J Clin Oncol 2011;16:210-20. [DOI: 10.1007/s10147-010-0150-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
401 Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging. 2009;34:371-380. [PMID: 18463915 DOI: 10.1007/s00261-008-9408-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
402 Puza CJ, Wang Q, Kim CY. Evaluation of the Heat Sink Effect After Transarterial Embolization When Performed in Combination with Thermal Ablation of the Liver in a Rabbit Model. Cardiovasc Intervent Radiol 2018;41:1773-8. [PMID: 30039505 DOI: 10.1007/s00270-018-2034-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
403 Ju JX, Zeng QJ, Xu EJ, He XQ, Tan L, Huang QN, Li K, Zheng RQ. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound. Int J Hyperthermia 2019;36:785-93. [PMID: 31431086 DOI: 10.1080/02656736.2019.1640899] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
404 Tam AL, Melancon MP, Abdelsalam M, Figueira TA, Dixon K, McWatters A, Zhou M, Huang Q, Mawlawi O, Dunner K Jr, Li C, Gupta S. Imaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors. J Biomed Nanotechnol 2016;12:296-307. [PMID: 27305763 DOI: 10.1166/jbn.2016.2174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
405 Sharma DN, Thulkar S, Sharma S, Gandhi AK, Haresh KP, Gupta S, Rath GK, Julka PK. High-dose-rate interstitial brachytherapy for liver metastases: first study from India. J Contemp Brachytherapy 2013;5:70-5. [PMID: 23878550 DOI: 10.5114/jcb.2013.36175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
406 Zhu Q, Shen Y, Zhang A, Xu LX. Numerical study of the influence of water evaporation on radiofrequency ablation. Biomed Eng Online 2013;12:127. [PMID: 24325296 DOI: 10.1186/1475-925X-12-127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
407 Hiraoka A, Kumada T, Hirooka M, Tsuji K, Itobayashi E, Kariyama K, Ishikawa T, Tajiri K, Ochi H, Tada T, Toyoda H, Nouso K, Joko K, Kawasaki H, Hiasa Y, Michitaka K; Real-life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics). A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin grade. Hepatol Res 2018;48:E61-7. [PMID: 28628718 DOI: 10.1111/hepr.12927] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
408 Yeung YP, Hui J, Yip WCA. Delayed Colonic Perforation After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2007;17:342-4. [DOI: 10.1097/sle.0b013e31805f704e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
409 Zhao L, Chen Z, Wang J, Yang L, Zhao Q, Wang J, Qi Q, Mu R, You Q, Guo Q. Synergistic effect of 5-fluorouracil and the flavanoid oroxylin A on HepG2 human hepatocellular carcinoma and on H22 transplanted mice. Cancer Chemother Pharmacol 2010;65:481-9. [DOI: 10.1007/s00280-009-1053-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
410 Kageyama K, Yamamoto A, Okuma T, Hamamoto S, Takeshita T, Sakai Y, Nishida N, Matsuoka T, Miki Y. Radiofrequency Ablation of Liver Tumors in Combination with Local OK-432 Injection Prolongs Survival and Suppresses Distant Tumor Growth in the Rabbit Model with Intra- and Extrahepatic VX2 Tumors. Cardiovasc Intervent Radiol 2013;36:1383-92. [DOI: 10.1007/s00270-013-0650-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
411 Wakai T, Shirai Y, Suda T, Yokoyama N, Sakata J, Cruz PV, Kawai H, Matsuda Y, Watanabe M, Aoyagi Y, Hatakeyama K. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma ≤ 4 cm. World J Gastroenterol 2006; 12(4): 546-552 [PMID: 16489666 DOI: 10.3748/wjg.v12.i4.546] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
412 Takahashi H, Mizuta T, Kawazoe S, Eguchi Y, Kawaguchi Y, Otuka T, Oeda S, Ario K, Iwane S, Akiyama T, Ozaki I, Fujimoto K. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients: RFA for elderly HCC patients. Hepatology Research 2010;40:997-1005. [DOI: 10.1111/j.1872-034x.2010.00713.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
413 Lee J, Lim HK, Choi D, Kim SH, Min K, Jeon YH. Radiofrequency ablation of the liver abutting stomach: in vivo comparison of gastric injury before and after intragastric saline administration in a porcine model. Eur J Radiol 2009;72:154-9. [PMID: 18684577 DOI: 10.1016/j.ejrad.2008.06.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
414 Schullian P, Putzer D, Silva MA, Laimer G, Kolbitsch C, Bale R. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians. Front Oncol 2019;9:929. [PMID: 31608232 DOI: 10.3389/fonc.2019.00929] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
415 Lee C, Chen W, Lin C, Teng W, Lin S, Chiu C. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations. The Kaohsiung Journal of Medical Sciences 2015;31:413-9. [DOI: 10.1016/j.kjms.2015.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
416 Park W, Chung YH, Kim JA, Jin YJ, Lee D, Shim JH, Lee D, Kim KM, Lim YS, Lee HC. Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns. Hepatol Res. 2013;43:1304-1312. [PMID: 23442052 DOI: 10.1111/hepr.12083] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
417 Shibuya K, Ohno T, Katoh H, Okamoto M, Shiba S, Koyama Y, Kakizaki S, Shirabe K, Nakano T. A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger. Radiother Oncol 2019;132:230-5. [PMID: 30366726 DOI: 10.1016/j.radonc.2018.10.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
418 Wong SN, Santi GE, Nurjadin H, Aguilar R, Gosalvez-Pe S. Temperature-dependent electrode repositioning for multiple overlapping radiofrequency ablation in ex vivo porcine livers. J Vasc Interv Radiol 2010;21:1733-8. [PMID: 20884231 DOI: 10.1016/j.jvir.2010.07.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
419 Ng KK, Poon RT, Lo C, Yuen J, Tso WK, Fan S. Analysis of Recurrence Pattern and Its Influence on Survival Outcome After Radiofrequency Ablation of Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:183-91. [DOI: 10.1007/s11605-007-0276-y] [Cited by in Crossref: 115] [Cited by in F6Publishing: 116] [Article Influence: 7.7] [Reference Citation Analysis]
420 Clasen S, Boss A, Schmidt D, Schraml C, Fritz J, Schick F, Claussen CD, Pereira PL. MR-guided radiofrequency ablation in a 0.2-T open MR system: Technical success and technique effectiveness in 100 liver tumors. J Magn Reson Imaging 2007;26:1043-52. [DOI: 10.1002/jmri.21120] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
421 Kariyama K, Nouso K, Wakuta A, Oonishi A, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Takaguchi K, Tsutsui A, Shimada N, Kumada T. Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies. Liver Cancer 2020;9:41-9. [PMID: 32071908 DOI: 10.1159/000502479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
422 Lencioni R, Crocetti L, Pina MCD, Cioni D. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009;34:547-56. [DOI: 10.1007/s00261-008-9479-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
423 Weinberg BD, Patel RB, Exner AA, Saidel GM, Gao J. Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. J Control Release 2007;124:11-9. [PMID: 17900740 DOI: 10.1016/j.jconrel.2007.08.023] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
424 Azuma S, Asahina Y, Nishimura-sakurai Y, Kakinuma S, Kaneko S, Nagata H, Goto F, Ootani S, Kawai-kitahata F, Taniguchi M, Murakawa M, Watanabe T, Tasaka-fujita M, Itsui Y, Nakagawa M, Watanabe M. Efficacy of additional radiofrequency ablation after transcatheter arterial chemoembolization for intermediate hepatocellular carcinoma: Additional RFA after TACE for intermediate HCC. Hepatol Res 2016;46:312-9. [DOI: 10.1111/hepr.12566] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
425 Kisaka Y, Hirooka M, Koizumi Y, Abe M, Matsuura B, Hiasa Y, Onji M. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma. J Clin Ultrasound. 2010;38:138-144. [PMID: 20014137 DOI: 10.1002/jcu.20654] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
426 Caspani B, Ierardi AM, Motta F, Cecconi P, Fesce E, Belli L. Small nodular hepatocellular carcinoma treated by laser thermal ablation in high risk locations: preliminary results. Eur Radiol 2010;20:2286-92. [DOI: 10.1007/s00330-010-1766-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
427 Thomasset SC, Dennison AR, Garcea G. Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg. 2015;39:1150-1160. [PMID: 25634340 DOI: 10.1007/s00268-015-2956-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
428 Seinstra BA, van Delden OM, van Erpecum KJ, van Hillegersberg R, Mali WP, van den Bosch MA. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? Insights Imaging. 2010;1:167-181. [PMID: 23100194 DOI: 10.1007/s13244-010-0027-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
429 Fan RF, Chai FL, He GX, Wei LX, Li RZ, Wan WX, Bai MD, Zhu WK, Cao ML, Li HM. Laparoscopic radiofrequency ablation of hepatic cavernous hemangioma. A preliminary experience with 27 patients. Surg Endosc. 2006;20:281-285. [PMID: 16362478 DOI: 10.1007/s00464-005-0184-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
430 Amano K, Kawaguchi T, Kuromatsu R, Kawaguchi A, Miyajima I, Ide T, Kakuma T, Sata M. Time trends of clinical characteristics in hepatocellular carcinoma patients with chronic hepatitis B virus infection: A field survey between 2000 and 2012. Mol Clin Oncol 2014;2:927-34. [PMID: 25279176 DOI: 10.3892/mco.2014.398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
431 Rhim H, Lim HK, Kim Y, Choi D, Lee KT. Hemobilia after radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging 2007;32:719-24. [DOI: 10.1007/s00261-006-9158-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
432 Toyoda M, Kakizaki S, Horiuchi K, Katakai K, Sohara N, Sato K, Takagi H, Mori M, Nakajima T. Computed tomography-guided transpulmonary radiofrequency ablation for hepatocellular carcinoma located in hepatic dome. World J Gastroenterol 2006; 12(4): 608-611 [PMID: 16489676 DOI: 10.3748/wjg.v12.i4.608] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
433 McWilliams JP, Yamamoto S, Raman SS, Loh CT, Lee EW, Liu DM, Kee ST. Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol. 2010;21:S204-S213. [PMID: 20656230 DOI: 10.1016/j.jvir.2009.11.025] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
434 Uyama H, Nagano H, Nakamura H, Murakami T, Nakamura H, Monden M, Hayashi N. New chemotherapy for patients with advanced hepatocellular carcinoma: Pilot study of β-interferon and doxorubicin one-shot intra-arterial chemotherapy. Hepatology Research 2007;37:1018-25. [DOI: 10.1111/j.1872-034x.2007.00158.x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
435 Hermida M, Cassinotto C, Piron L, Aho-Glélé S, Guillot C, Schembri V, Allimant C, Jaber S, Pageaux GP, Assenat E, Guiu B. Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients. Cancers (Basel) 2020;12:E313. [PMID: 32013112 DOI: 10.3390/cancers12020313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
436 Tsuchiya K, Asahina Y, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Nakanishi H, Itakura J, Kurosaki M, Enomoto N. Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Liver Transpl. 2014;20:291-297. [PMID: 24734314 DOI: 10.1002/lt.23798] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
437 Korean Liver Cancer Study Group and National Cancer Center, Korea. [Practice guidelines for management of hepatocellular carcinoma 2009]. Korean J Hepatol. 2009;15:391-423. [PMID: 19783891 DOI: 10.3350/kjhep.2009.15.3.391] [Cited by in Crossref: 182] [Cited by in F6Publishing: 183] [Article Influence: 15.2] [Reference Citation Analysis]
438 Yamashiki N, Tateishi R, Yoshida H, Shiina S, Teratani T, Sato S, Mine N, Kondo Y, Kawabe T, Omata M. Ablation therapy in containing extension of hepatocellular carcinoma: a simulative analysis of dropout from the waiting list for liver transplantation. Liver Transpl. 2005;11:508-514. [PMID: 15838878 DOI: 10.1002/lt.20392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
439 Ito T, Tanaka S, Iwai S, Takemura S, Hagihara A, Uchida-kobayashi S, Shinkawa H, Nishioka T, Kawada N, Kubo S. Outcomes of laparoscopic hepatic resection versus percutaneous radiofrequency ablation for hepatocellular carcinoma located at the liver surface: A case-control study with propensity score matching: Laparoscopic hepatectomy for surface HCC. Hepatol Res 2016;46:565-74. [DOI: 10.1111/hepr.12592] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
440 Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Shimizu Y, Shiraishi A, Yamago H, Tanihira T, Miyata H, Ninomiya T, Kawasaki H, Ishimaru Y, Sogabe I, Inoue T, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: Impact of FDG PET/CT. Liver Int. 2013;33:1085-1091. [PMID: 23601196 DOI: 10.1111/liv.12161] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
441 Gao J, Zhang Q, Zhang J, Kong J, Wang S, Ding X, Ke S, Sun W. Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative: Two Case Reports. Medicine (Baltimore) 2015;94:e1122. [PMID: 26166111 DOI: 10.1097/MD.0000000000001122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
442 Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Nakata T, Nishimura T, Suzuki S, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Izumi N. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J Gastroenterol 2013; 19(2): 249-257 [PMID: 23345948 DOI: 10.3748/wjg.v19.i2.249] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
443 Shiina S. Japanese experience in ablation therapies for hepatocellular carcinoma. Hepatology Research 2007;37:S223-9. [DOI: 10.1111/j.1872-034x.2007.00189.x] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
444 Sugimoto K, Moriyasu F, Shiraishi J, Yamada M, Imai Y. A phantom study comparing ultrasound-guided liver tumor puncture using new real-time 3D ultrasound and conventional 2D ultrasound. AJR Am J Roentgenol 2011;196:W753-7. [PMID: 21606264 DOI: 10.2214/AJR.10.5552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
445 Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66:347-354. [PMID: 27650284 DOI: 10.1016/j.jhep.2016.09.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
446 de la Serna S, Vilana R, Sánchez-Cabús S, Calatayud D, Ferrer J, Molina V, Fondevila C, Bruix J, Fuster J, García-Valdecasas JC. Results of laparoscopic radiofrequency ablation for HCC. Could the location of the tumour influence a complete response to treatment? A single European centre experience. HPB (Oxford). 2015;17:387-393. [PMID: 25545319 DOI: 10.1111/hpb.12379] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
447 Lloyd DM, Lau KN, Welsh F, Lee KF, Sherlock DJ, Choti MA, Martinie JB, Iannitti DA. International multicentre prospective study on microwave ablation of liver tumours: preliminary results. HPB (Oxford). 2011;13:579-585. [PMID: 21762302 DOI: 10.1111/j.1477-2574.2011.00338.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
448 Wong PY, Xia V, Imagawa DK, Hoefs J, Hu KQ. Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. J Immigr Minor Health 2011;13:842-8. [PMID: 20890660 DOI: 10.1007/s10903-010-9395-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
449 Miyayama S, Yamashiro M, Ikuno M, Okumura K, Yoshida M. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response. Abdom Imaging 2014;39:645-56. [DOI: 10.1007/s00261-014-0094-0] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
450 Poon RT, Borys N. Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opin Pharmacother 2009;10:333-43. [PMID: 19236203 DOI: 10.1517/14656560802677874] [Cited by in Crossref: 131] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
451 Nakagawa H, Maeda S. Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK. Patholog Res Int 2012;2012:172894. [PMID: 22666632 DOI: 10.1155/2012/172894] [Cited by in Crossref: 33] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
452 Pan J, Li X, He Y, Jian C, Chen HX, Hei Z, Zhou S. Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial. Trials 2019;20:28. [PMID: 30621749 DOI: 10.1186/s13063-018-3010-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
453 Hakimé A, Hines-Peralta A, Peddi H, Atkins MB, Sukhatme VP, Signoretti S, Regan M, Goldberg SN. Combination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in mice. Radiology. 2007;244:464-470. [PMID: 17641366 DOI: 10.1148/radiol.2442061005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.7] [Reference Citation Analysis]
454 Meng LM, Zhiyan LM, Yuejuan GM, Jiangke TM, Min CM, Jinghui DM. Safety and Efficacy of Percutaneous Radiofrequency Ablation Combined with Percutaneous Ethanol Injection for Hepatocellular Carcinoma in High-risk Locations. Advanced Ultrasound in Diagnosis and Therapy 2018;2:1. [DOI: 10.37015/audt.2018.180004] [Reference Citation Analysis]
455 Hata M, Tokuuye K, Sugahara S, Fukumitsu N, Hashimoto T, Ohnishi K, Nemoto K, Ohara K, Matsuzaki Y, Akine Y. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis. Strahlenther Onkol 2006;182:713-20. [PMID: 17149578 DOI: 10.1007/s00066-006-1564-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
456 Iezzi R, Cesario V, Siciliani L, Campanale M, De Gaetano AM, Siciliano M, Agnes S, Giuliante F, Grieco A, Pompili M, Rapaccini GL, Gasbarrini A, Bonomo L, HepatoCATT Group for the Multidisciplinary Management of HCC. Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE). Radiol Med. 2013;118:555-569. [PMID: 23358819 DOI: 10.1007/s11547-012-0914-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
457 Kim TH, Choi HI, Kim BR, Kang JH, Nam JG, Park SJ, Lee S, Yoon JH, Lee DH, Joo I, Lee JM. No-Touch Radiofrequency Ablation of VX2 Hepatic Tumors In Vivo in Rabbits: A Proof of Concept Study. Korean J Radiol 2018;19:1099-109. [PMID: 30386141 DOI: 10.3348/kjr.2018.19.6.1099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
458 Chava S, Lee C, Aydin Y, Chandra PK, Dash A, Chedid M, Thung SN, Moroz K, Wu T, Nayak NC, Dash S. Chaperone-mediated autophagy compensates for impaired macroautophagy in the cirrhotic liver to promote hepatocellular carcinoma. Oncotarget 2017;8:40019-36. [PMID: 28402954 DOI: 10.18632/oncotarget.16685] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
459 Chiang J, Lin C, Wang J, Kee K, Chen P, Chen Y, Tsai L, Chen TH, Lu S. Identifying hepatitis C virus: endemic areas and estimating the viral antibody prevalence based on the prevalence of ALT elevation. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009;103:917-23. [DOI: 10.1016/j.trstmh.2009.03.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
460 Goto E, Tateishi R, Shiina S, Masuzaki R, Enooku K, Sato T, Ohki T, Kondo Y, Goto T, Yoshida H. Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol. 2010;44:374-380. [PMID: 19809357 DOI: 10.1097/mcg.0b013e3181b7ed76] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
461 Zhang Y, Liang H, Chen M, Guo R, Li J, Zheng Y, Zhang Y, Lau WY. Hepatocellular Carcinoma Treated with Radiofrequency Ablation with or without Ethanol Injection: A Prospective Randomized Trial. Radiology 2007;244:599-607. [DOI: 10.1148/radiol.2442060826] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 6.9] [Reference Citation Analysis]
462 Liang HH, Chen MS, Peng ZW, Zhang YJ, Zhang YQ, Li JQ, Lau WY. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol. 2008;15:3484-3493. [PMID: 18679754 DOI: 10.1245/s10434-008-0076-y] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 5.4] [Reference Citation Analysis]
463 Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, Park CK. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur Radiol 2008;18:814-21. [PMID: 18080127 DOI: 10.1007/s00330-007-0823-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
464 Labori KJ, Schulz A, Drolsum A, Guren MG, Kløw NE, Bjørnbeth BA. Radiofrequency ablation of unresectable colorectal liver metastases: trends in management and outcome during a decade at a single center. Acta Radiol Open. 2015;4:2058460115580877. [PMID: 26346740 DOI: 10.1177/2058460115580877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
465 Melancon MP, Appleton Figueira T, Fuentes DT, Tian L, Qiao Y, Gu J, Gagea M, Ensor JE, Muñoz NM, Maldonado KL, Dixon K, McWatters A, Mitchell J, McArthur M, Gupta S, Tam AL. Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases. Radiology 2018;286:149-57. [PMID: 28825892 DOI: 10.1148/radiol.2017161721] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
466 Snoeren N, Huiskens J, Rijken AM, van Hillegersberg R, van Erkel AR, Slooter GD, Klaase JM, van den Tol PM, Ten Kate FJ, Jansen MC, van Gulik TM. Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol 2011;18:3702-10. [PMID: 21590455 DOI: 10.1245/s10434-011-1762-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
467 Rim CH, Lee HY, Kim JS, Kim H. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile? Int J Radiat Biol 2021;97:111-9. [PMID: 33253598 DOI: 10.1080/09553002.2021.1857453] [Reference Citation Analysis]
468 Cheng JW, Lv Y. New progress of non-surgical treatments for hepatocellular carcinoma. Med Oncol 2013;30:381. [PMID: 23292867 DOI: 10.1007/s12032-012-0381-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
469 Ni JY, Liu SS, Xu LF, Sun HL, Chen YT. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2013; 19(24): 3872-3882 [PMID: 23840128 DOI: 10.3748/wjg.v19.i24.3872] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 85] [Article Influence: 10.2] [Reference Citation Analysis]
470 Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas. World J Gastrointest Surg 2010; 2(4): 137-142 [PMID: 21160862 DOI: 10.4240/wjgs.v2.i4.137] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
471 Breen DJ, Lencioni R. Image-guided ablation of primary liver and renal tumours. Nat Rev Clin Oncol. 2015;12:175-186. [PMID: 25601446 DOI: 10.1038/nrclinonc.2014.237] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
472 Clasen S, Pereira P. Interventionelle Kombinationstherapien. Radiologe 2007;47:1072-82. [DOI: 10.1007/s00117-007-1589-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
473 Andersson KL, Salomon JA, Goldie SJ, Chung RT. Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol. 2008;6:1418-1424. [PMID: 18848905 DOI: 10.1016/j.cgh.2008.08.005] [Cited by in Crossref: 139] [Cited by in F6Publishing: 118] [Article Influence: 9.9] [Reference Citation Analysis]
474 Yamane B, Weber S. Liver-Directed Treatment Modalities for Primary and Secondary Hepatic Tumors. Surgical Clinics of North America 2009;89:97-113. [DOI: 10.1016/j.suc.2008.10.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
475 Choi JW, Lee JM, Kim HC, Lee M, Hur S, Jae HJ, Chung JW. Iatrogenic Arterioportal Fistula Caused by Radiofrequency Ablation of Hepatocellular Carcinoma: Clinical Course and Treatment Outcomes. J Vasc Interv Radiol 2020;31:728-36. [PMID: 32229078 DOI: 10.1016/j.jvir.2019.10.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
476 Lei P, Moeslein F, Wood BJ, Shekhar R. Real-time tracking of liver motion and deformation using a flexible needle. Int J Comput Assist Radiol Surg 2011;6:435-46. [PMID: 20700662 DOI: 10.1007/s11548-010-0523-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
477 Yu LH, Li N, Shi J, Guo WX, Wu MC, Cheng SQ. Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy? Ann Surg Oncol. 2014;21:1010-1015. [PMID: 24121884 DOI: 10.1245/s10434-013-3320-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
478 Masuzaki R, Shiina S, Tateishi R, Yoshida H, Goto E, Sugioka Y, Kondo Y, Goto T, Ikeda H, Omata M, Koike K. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:759-764. [PMID: 21054516 DOI: 10.1111/j.1440-1746.2010.06559.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
479 Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study. Eur Radiol 2018;28:3522-31. [PMID: 29536241 DOI: 10.1007/s00330-017-5166-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
480 Tan Y, Wang X, Ma K, Zhang L, Li J, Chen P, Zhang B. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study. Int J Hyperthermia 2022;39:190-9. [PMID: 35042449 DOI: 10.1080/02656736.2021.2024279] [Reference Citation Analysis]
481 Kambadakone A, Baliyan V, Kordbacheh H, Uppot RN, Thabet A, Gervais DA, Arellano RS. Imaging guided percutaneous interventions in hepatic dome lesions: Tips and tricks. World J Hepatol 2017; 9(19): 840-849 [PMID: 28740595 DOI: 10.4254/wjh.v9.i19.840] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
482 Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89. [PMID: 18008357 DOI: 10.1002/hep.21933] [Cited by in Crossref: 705] [Cited by in F6Publishing: 654] [Article Influence: 50.4] [Reference Citation Analysis]
483 Cho YK, Kim JK, Kim WT, Chung JW. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology. 2010;51:1284-1290. [PMID: 20099299 DOI: 10.1002/hep.23466] [Cited by in Crossref: 171] [Cited by in F6Publishing: 148] [Article Influence: 14.3] [Reference Citation Analysis]
484 Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. Eur J Surg Oncol. 2010;36:257-263. [PMID: 19643561 DOI: 10.1016/j.ejso.2009.07.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
485 Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RS, Diniz MA, Alves VA, D’Albuquerque LAC, Carrilho FJ. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival. World J Gastroenterol 2014; 20(6): 1585-1593 [PMID: 24587635 DOI: 10.3748/wjg.v20.i6.1585] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
486 Brunot A, Le Sourd S, Pracht M, Edeline J. Hepatocellular carcinoma in elderly patients: challenges and solutions. J Hepatocell Carcinoma. 2016;3:9-18. [PMID: 27574587 DOI: 10.2147/jhc.s101448] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
487 Xie H, Wang H, An W, Ma W, Qi R, Yang B, Liu C, Gao Y, Xu B, Wang W. The efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization for primary hepatocellular carcinoma in a cohort of 487 patients. PLoS One. 2014;9:e89081. [PMID: 24586515 DOI: 10.1371/journal.pone.0089081] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
488 Nam SY, Rhim H, Kang TW, Lee MW, Kim Y, Choi D, Lee WJ, Park Y, Chang I, Lim HK. Percutaneous Radiofrequency Ablation for Hepatic Tumors Abutting the Diaphragm: Clinical Assessment of the Heat-Sink Effect of Artificial Ascites. American Journal of Roentgenology 2010;194:W227-31. [DOI: 10.2214/ajr.09.2979] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
489 Kisaka Y, Hirooka M, Kumagi T, Uehara T, Hiasa Y, Kumano S, Tanaka H, Michitaka K, Horiike N, Mochizuki T, Onji M. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation. Liver Int 2006;26:1241-7. [DOI: 10.1111/j.1478-3231.2006.01367.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
490 Takaki H, Yamakado K, Uraki J, Nakatsuka A, Fuke H, Yamamoto N, Shiraki K, Yamada T, Takeda K. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol. 2009;20:217-224. [PMID: 19097810 DOI: 10.1016/j.jvir.2008.10.019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
491 Qi H, Zhang H, Wan C, Xie L, Song Z, Fan W. CT-guided microwave ablation through the lungs for treating liver tumors near the diaphragm. Oncotarget 2017;8:79270-8. [PMID: 29108305 DOI: 10.18632/oncotarget.17422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
492 Lahat E, Eshkenazy R, Zendel A, Zakai BB, Maor M, Dreznik Y, Ariche A. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg Nutr. 2014;3:317-323. [PMID: 25392844 DOI: 10.3978/j.issn.2304-3881.2014.09.07] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
493 Han J, Fan YC, Wang K. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22703. [PMID: 33120763 DOI: 10.1097/MD.0000000000022703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
494 Wong J, Lee KF, Yu SC, Lee PS, Cheung YS, Chong CN, Ip PC, Lai PB. Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results. HPB (Oxford) 2013;15:595-601. [PMID: 23458320 DOI: 10.1111/hpb.12014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
495 Koo JH, Shin JH, Oh YL, Ko EY, Han B. Sonographically Guided Radiofrequency Ablation With and Without a Superficial Saline Injection to Prevent Skin Burns in a Rabbit Model. Journal of Ultrasound in Medicine 2012;31:873-8. [DOI: 10.7863/jum.2012.31.6.873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
496 Stoltz A, Gagnière J, Dupré A, Rivoire M. Radiofrequency ablation for colorectal liver metastases. J Visc Surg 2014;151 Suppl 1:S33-44. [PMID: 24582728 DOI: 10.1016/j.jviscsurg.2013.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
497 Lee S, Rhim H, Kim YS, Kang TW, Song KD. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Liver Int 2016;36:580-7. [PMID: 26503910 DOI: 10.1111/liv.12991] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
498 Gervais DA, Arellano RS. Percutaneous tumor ablation for hepatocellular carcinoma. AJR Am J Roentgenol. 2011;197:789-794. [PMID: 21940565 DOI: 10.2214/ajr.11.7656] [Cited by in Crossref: 46] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
499 de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. Journal of Hepatology 2012;56:S75-87. [DOI: 10.1016/s0168-8278(12)60009-9] [Cited by in Crossref: 363] [Cited by in F6Publishing: 201] [Article Influence: 36.3] [Reference Citation Analysis]
500 Izumi N. Recent advances of radiofrequency ablation for early hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26 Suppl 1:115-122. [PMID: 21199522 DOI: 10.1111/j.1440-1746.2010.06543.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
501 Imamura J, Tateishi R, Shiina S, Goto E, Sato T, Ohki T, Masuzaki R, Goto T, Yoshida H, Kanai F, Hamamura K, Obi S, Yoshida H, Omata M. Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology 2008;103:3057-62. [DOI: 10.1111/j.1572-0241.2008.02153.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
502 Nishikawa H, Osaki Y. Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatol Res. 2014;44:149-158. [PMID: 23819582 DOI: 10.1111/hepr.12194] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
503 Mizumoto M, Okumura T, Hashimoto T, Fukuda K, Oshiro Y, Fukumitsu N, Abei M, Kawaguchi A, Hayashi Y, Ookawa A, Hashii H, Kanemoto A, Moritake T, Tohno E, Tsuboi K, Sakae T, Sakurai H. Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys. 2011;81:1039-1045. [PMID: 20888707 DOI: 10.1016/j.ijrobp.2010.07.015] [Cited by in Crossref: 102] [Cited by in F6Publishing: 85] [Article Influence: 8.5] [Reference Citation Analysis]
504 Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, Yamanaka T, Shiraki K, Takei Y, Takeda K. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol 2013;18:46-53. [DOI: 10.1007/s10147-011-0340-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
505 Li Y, Shi G, Wang S, Wang S, Wu R. Iodine quantification with dual-energy CT: phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation. Br J Radiol 2013;86:20130143. [PMID: 23884759 DOI: 10.1259/bjr.20130143] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
506 Kondo Y, Yoshida H, Tateishi R, Shiina S, Mine N, Yamashiki N, Sato S, Kato N, Kanai F, Yanase M. Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:197-203. [PMID: 17295871 DOI: 10.1111/j.1440-1746.2006.04456.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
507 Hu XY, Li L, Wu HT, Liu Y, Wang BD, Tang Y. Serum miR-130b level, an ideal marker for monitoring the recurrence and prognosis of primary hepatocellular carcinoma after radiofrequency ablation treatment. Pathol Res Pract 2018;214:1655-60. [PMID: 30153957 DOI: 10.1016/j.prp.2018.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
508 Sato M, Tateishi R, Yasunaga H, Matsui H, Fushimi K, Ikeda H, Yatomi Y, Koike K. In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database. BJR Open. 2019;1:20190004. [PMID: 33178938 DOI: 10.1259/bjro.20190004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
509 Takahashi S, Kudo M, Chung H, Inoue T, Nagashima M, Kitai S, Tatsumi C, Minami Y, Ueshima K, Fukunaga T. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis. 2007;25:303-309. [PMID: 17960064 DOI: 10.1159/000106909] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
510 Rodríguez-Sanjuán JC, González F, Juanco C, Herrera LA, López-Bautista M, González-Noriega M, García-Somacarrera E, Figols J, Gómez-Fleitas M, Silván M. Radiological and pathological assessment of hepatocellular carcinoma response to radiofrequency. A study on removed liver after transplantation. World J Surg. 2008;32:1489-1494. [PMID: 18373117 DOI: 10.1007/s00268-008-9559-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
511 Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005 [PMID: 26973395 DOI: 10.3748/wjg.v22.i10.2993] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
512 Teng W, Liu KW, Lin CC, Jeng WJ, Chen WT, Sheen IS, Lin CY, Lin SM. Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation. Liver Cancer 2015;4:26-38. [PMID: 26020027 DOI: 10.1159/000343877] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
513 Mikami S, Tateishi R, Akahane M, Asaoka Y, Kondo Y, Goto T, Shiina S, Yoshida H, Koike K. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience. J Vasc Interv Radiol. 2012;23:1269-1275. [PMID: 22999746 DOI: 10.1016/j.jvir.2012.06.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
514 Park MH, Cho JS, Shin BS, Jeon GS, Lee B, Lee K. Comparison of internally cooled wet electrode and hepatic vascular inflow occlusion method for hepatic radiofrequency ablation. Gut Liver 2012;6:471-5. [PMID: 23170152 DOI: 10.5009/gnl.2012.6.4.471] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
515 Itri JN, Heller MT, Tublin ME. Hepatic transplantation: postoperative complications. Abdom Imaging. 2013;38:1300-1333. [PMID: 23644931 DOI: 10.1007/s00261-013-0002-z] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
516 Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol. 2010;36:1054-1060. [PMID: 20846819 DOI: 10.1016/j.ejso.2010.08.133] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
517 Winkler I, Adam D. Monitoring Radio-Frequency Thermal Ablation with Ultrasound by Low Frequency Acoustic Emissions – In Vitro and In Vivo Study. Ultrasound in Medicine & Biology 2011;37:755-67. [DOI: 10.1016/j.ultrasmedbio.2010.11.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
518 Ma S, Ding M, Li J, Wang T, Qi X, Shi Y, Ming Y, Chi J, Wang Z, Tang X, Cui D, Zhang Y, Zhai B. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol 2017;143:131-42. [DOI: 10.1007/s00432-016-2266-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
519 Besler E, Curtis Wang Y, C Chan T, V Sahakian A. Real-time monitoring radiofrequency ablation using tree-based ensemble learning models. Int J Hyperthermia 2019;36:428-37. [PMID: 30939953 DOI: 10.1080/02656736.2019.1587008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
520 Jeong YS, Kim SH, Lee JM, Lee JY, Kim JH, Lee DH, Kang HJ, Yoon CJ, Han JK. Gastrointestinal tract complications after hepatic radiofrequency ablation: CT prediction for major complications. Abdom Radiol (NY). 2018;43:583-592. [PMID: 28676999 DOI: 10.1007/s00261-017-1239-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
521 Bruix J, Sherman M;  Practice Guidelines Committee;  American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. [PMID: 16250051 DOI: 10.1002/hep.20933] [Cited by in Crossref: 4104] [Cited by in F6Publishing: 3893] [Article Influence: 241.4] [Reference Citation Analysis]
522 Ha J, Wong RJ. Nonsurgical options for localized hepatocellular carcinoma. Clin Liver Dis (Hoboken) 2017;10:103-6. [PMID: 31186897 DOI: 10.1002/cld.662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
523 Ma X, Arellano RS, Gervais DA, Hahn PF, Mueller PR, Sahani DV. Success of image-guided biopsy for small (≤ 3 cm) focal liver lesions in cirrhotic and noncirrhotic individuals. J Vasc Interv Radiol 2010;21:1539-47; quiz 1547. [PMID: 20801683 DOI: 10.1016/j.jvir.2010.05.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
524 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 684] [Cited by in F6Publishing: 685] [Article Influence: 57.0] [Reference Citation Analysis]
525 Cha J, Rhim H, Lee JY, Kim YS, Choi D, Lee MW, Lee WJ, Lim HK. Percutaneous radiofrequency ablation of hepatocellular carcinoma: assessment of safety in patients with ascites. AJR Am J Roentgenol 2009;193:W424-9. [PMID: 19843722 DOI: 10.2214/AJR.08.1836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
526 Uchino K, Tateishi R, Shiina S, Kanda M, Masuzaki R, Kondo Y, Goto T, Omata M, Yoshida H, Koike K. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer. 2011;117:4475-4483. [PMID: 21437884 DOI: 10.1002/cncr.25960] [Cited by in Crossref: 228] [Cited by in F6Publishing: 209] [Article Influence: 20.7] [Reference Citation Analysis]
527 Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N, Kubo S, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kokudo T, Kashiwabara K, Kudo M. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017;6:325-336. [PMID: 29234636 DOI: 10.1159/000479984] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
528 Chang NK, Shin SS, Kim JW, Kim HJ, Jeong YY, Heo SH, Kim JK, Kang HK. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Korean J Radiol 2012;13 Suppl 1:S104-11. [PMID: 22563280 DOI: 10.3348/kjr.2012.13.S1.S104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
529 Massarweh NN, Park JO, Yeung RS, Flum DR. Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma. Ann Surg Oncol 2012;19:1058-65. [PMID: 21947695 DOI: 10.1245/s10434-011-2067-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
530 Kalra N, Kang M, Bhatia A, Duseja AK, Dhiman RK, Arya VK, Rajwanshi A, Chawla YK, Khandelwal N. Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience. Indian J Radiol Imaging. 2013;23:139-144. [PMID: 24082478 DOI: 10.4103/0971-3026.116569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
531 Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging. 2008;27:421-433. [PMID: 18219677 DOI: 10.1002/jmri.21264] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 5.8] [Reference Citation Analysis]